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Dedication: This book is respectfully dedicated to Professor Dongsik Bang, who has contributed 
significantly to the study of Behçet’s disease in Korea on the occasion of his retirement from 
professorship.

Early descriptions of the syndrome by Hippocrates in the 5th 
century BC: aphthous ulceration, genital ulceration, iridocyclitis 
with boils, sepsis, and ecthymata as skin lesions 
(In Epidimion, Book 3, Case 7 translated by Adams F, 1849) 
Turkish dermatologist Hûlusi Behçet first defined this triple 
symptom complex of “recurrent oral aphthous ulcers, genital 
ulcers, and uveitis” as a single disease entity in 1937.
(Dermatol Wochenschr 105:1152-7, 1937)
Geographical distribution of Behçet’s disease in the world which coincides with the Silk Route.
This disease was suggested as “Silk Route Disease” by Professor Shigeaki Ohno in 1985.
(Recent advance in Behçet’s disease 181-6,1985; Yonsei Med J 53:35-42, 2012) 
Professor Hûlusi Behçet (1881-1948)

Foreword
Although Professor Hûlusi  Behçet at the Cerrahpasa Medical School 
of University of Istanbul, Turkey, first reported this very important disease 
in 1937, Behçet’s disease has already been known to be present for many 
years. For example, in Epidimion, Book 3, which was written by an ancient 
Greek physician, Hippocrates in the 5th century BC, this disease was 
already clearly described. Dr Zhong Jing Zhang in China also reported a 
disease called as Hu Huo Bing in about 200 AD, which is compatible with 
Behçet’s disease. In Korea, there was an old description in which a woman doctor, Chan Gum, the Lady of 
the Court, found the disease of the King Jungjong to be Hu Huo Bing, and advised the treatment in 16th 
century. 
 
Therefore, Behçet ’s disease has a long history and the condition seems to have been endemic along the 
ancient “Silk Route” from Mediterranean countries to the Far East such as China, Korea and Japan. This is 
one of the reasons why Behçet’s disease has extensively been studied in Korea for many years.   
There have been so many excellent basic and clinical studies on this difficult disease which were 
performed in Korea by many excellent Korean researchers and clinicians. It is needless to say that these 
Korean studies on Behçet’s disease have greatly contributed to the understanding of the disease mechanisms 
and the development of new diagnostic methods and treatment modalities. It is well known that in the 
International Society for Behçet’s Disease, world-famous Professor Sungnack Lee lead us as the President 
and Professor Dongsik Bang as the Secretary of this Society until 2012. Annual Academic Meeting of the 
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Korean Society for Behçet’s Disease was inaugurated in 1999, and the 14th Annual Meeting is also planned 
to be held in Korea this year.    
 I was recently informed that this year marks the 30th anniversary of the opening of the Behçet’s Disease 
Specialty Clinic, Yonsei University College of Medicine, Seoul, Korea, and The Korean Society for Behçet’s 
Disease is planning to publish a book on “Behçet’s Disease in Korea”. 
On behalf of the International Society for Behçet’s Disease, I would like to congratulate wholeheartedly 
Professor Dongsik Bang, President of The Korean Society for Behçet’s Disease, and all the members of the 
Society for their great efforts and continuous endeavor in the studies of Behçet’s disease. 
I am sure that this book will supply us with the most updated knowledge on Behçet’s disease, and I 
encourage young brilliant researchers and clinicians to study further the true disease mechanisms, and 
discover effective treatments  for difficult systemic conditions in the near future.   
Shigeaki Ohno, M.D., Ph.D.
President, International Society for Behçet’s Disease
President, International Ocular Behçet’s Disease Study Group
Professor Emeritus, Hokkaido University Graduate School of Medicine, Sapporo, Japan
Visiting Clinical Professor, Hokkaido University Hospital, Sapporo, Japan
Visiting Professor, Yokohama City University School of Medicine, Yokohama, Japan
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Preface
It is very meaningful to leave on record the progress in a single country of a rare, incurable disease from 
the first diagnosis up to the present. Although clinical data can be collected through scientific review of 
literature, documents cannot easily identify efforts of the researchers, composition of a patron, support of the 
government, or participation of in-country and international academic meetings to overcome a recalcitrant 
disease. 
This document covers, in chronological order, the history of Behçet’s disease in Korea from the first 
diagnosis in 1961 until now, the foundation of the Korean Society for Behçet’s Disease, the composition of 
the patron, joint researches, the opening of international joint meetings, participation in the International 
Society for Behçet’s Disease and organization of Behçet’s disease workshops or symposiums in the World 
Congress of Dermatology, and the international contribution of Korean research groups in the field of 
Behçet’s disease. This will become a good reference for the documentation of other diseases.
Data were collected centrally on the activities of members of the Korean Society for Behçet’s Disease based 
on the achievements of the Behçet’s Disease Specialty Clinic at Severance Hospital of Yonsei University 
College of Medicine, which is reaching its 30th anniversary this year as the first such clinic in Korea. We 
apologize if we have omitted any achievements made by Korean researchers and hope we can supplement 
such information in the revised edition.
It should always be remembered that all these records were made possible because of the contribution of 
Dr. Hûlusi Behçet, who first defined this disease as a single disease entity in 1937, patients with the disease 
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have trusted and followed their doctors, and colleagues have referred these patients to the experts. We hope 
these data will be a valuable reference not only in Korea but in other countries where Behçet’s disease shows 
a high prevalence.
We are grateful to everyone whose contribution has added greatly to the value of this book. We are 
especially grateful to the editorial staff, former and present executive committee members of the Korean 
Society for Behçet’s Disease, President Shigheaki Ohno, and all other colleagues from the International 
Society for Behçet’s Disease who has sent us a foreword and congratulatory remarks. We offer special thanks 
to our publisher, HANURI, for their support.
November, 2013.
Dongsik Bang, M.D., Ph.D.
President, The Korean Society for Behçet’s Disease
Former Secretary General, The International Society for Behçet’s Disease
Sungnack Lee, Dr.med.habil.
Honorary President, The Korean Society for Behçet’s Disease
Past President, The International Society for Behçet’s Disease 
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Behçet’s Disease in Korea (1961 ~ 2013)
Year Events, people, and achievement
1961  The first report of two Behçet’s disease patients in the Korean literature by the 
ophthalmologist Chang Ro Joo
1983  The Behçet’s Disease Specialty Clinic, which was the first of its kind in Korea, was opened 
at the Severance Hospital of Yonsei University College of Medicine.
1985  Professors Sungnack Lee and Dongsik Bang presented the first data on Behçet’s Disease in 
Korea at the 4th International Conference on Behçet’s Disease, London, UK.
1987  At the 5th International Conference on Behçet’s Disease, Kahler Plaza Hotel, Rochester, 
Minnesota, USA, Professors Sungnack Lee, Dongsik Bang, Eun-So Lee, and MS Kim 
participated with papers (oral presentation, posters).
1989  A list of publications on Behçet’s syndrome was published by The Behçet’s Disease Specialty 
Clinic, Yonsei University College of Medicine.
1990  Genetic, ultrastructural, and immunologic studies of Behçet’s disease in Korea were 
introduced by the research team of Behçet’s Disease Specialty Clinic at the Behçet’s Disease 
Symposium of Asia Pacific League Against Rheumatism (APLAR), Seoul, Korea.
1991  A poster entitled “Clinical Spectrum of Behçet’s Disease,” presented by Professor Dongsik 
Bang, was recognized with the Gold Award for Teaching Value at the 50th Annual Meeting 
of American Academy of Dermatology, in Dallas, USA.






1992  Professor Sungnack Lee, with the research team of the Behçet’s Disease Specialty 
Clinic, organized a special workshop of Behçet’s disease at the 18th World Congress of 
Dermatology in New York, USA.
1993  The 2nd Turkey-Korea Joint Meeting of Behçet’s Disease was held at Ajou University, 
Suwon, Korea.
  At the 6th International Conference on Behçet’s Disease, Paris, the research team of the 
Behçet’s Disease Specialty Clinic participated with papers (oral presentation, posters).
1994  The Behçet’s Disease Specialty Clinic was opened at Ajou University Hospital.
  Behçet’s disease was introduced in the 3rd edition of Dermatology text book by Korean 
Dermatological Association by Professor Dongsik Bang and Professor Sungnack Lee.
1995  The 3rd Korea-Turkey Joint Meeting of Behçet’s Disease was held at Istanbul University, 
Istanbul, Turkey.
  The 2nd list of publications on Behçet’s disease was published by the Behçet’s Disease 
Specialty Clinics of Severance Hospital of Yonsei University College of Medicine and Ajou 
University Hospital.
  A reference index related to Behçet’s Disease (3268 references, June 1994) was published by 
Professors Dongsik Bang, Eun-So Lee, and Sungnack Lee.
1996  At the 7th International Conference on Behçet’s Disease, Tunis, the research team of 
Behçet’s Disease Specialty Clinic participated with papers (oral presentation, posters).
  The venue for the year 2000, 9th International Conference on Behçet’s Disease was decided 
as Seoul at this conference.
  Behçet’s Disease was introduced by Professors Sungnack Lee, Dongsik Bang, and Eun-So 
Lee on the Clinical Dermatology.
1997  The 4th Turkey- Korea Joint Meeting of Behçet’s Disease was held at Hilton Hotel, Kyongju, 
Korea.
1998  The monograph of Behçet’s Disease was published in Korean by Professors Dongsik Bang, 
Eun-So Lee, and Sungnack Lee.
  The 2nd edition of a reference index related to Behçet’s Disease (4591 references, June 1998) 





  At the 8th International Conference on Behçet’s Disease, Bologna, the research team of 
Behçet’s Disease Specialty Clinic participated with papers (oral presentation, posters).
1999  The 5th Korea-Turkey Joint Meeting of Behçet’s Disease was held at Ankara University, 
Ankara, Turkey.
  A meeting regarding the organization of the Korean Academic Society for Behçet’s Disease 
was held, with 35 doctors who were interested in Behçet’s disease.
  The 1st Annual Academic Meeting of the Korean Study Group for Behçet’s Disease was 
held, with 87 members (www.behcet.or.kr). Professor Sungnack Lee was elected as the first 
president.
  Herpes virus and Behçet’s Disease was introduced by Professor Dongsik Bang at the 7th 
National Congress of Behçet’s Disease, Istanbul, Turkey.
2000  The 9th International Conference on Behçet’s Disease, Seoul, Korea was organized by 
President Sungnack Lee and Secretary General Dongsik Bang with local organizing 
committee.
  Professor Sungnack Lee was elected as Vice-President of the International Society for 
Behçet’s Disease.
  The first multicenter study on epidemiologic and clinical survey of Behçet’s Disease in 
Korea was conducted by the Korean Study Group for Behçet’s Disease.
  Professor Sungnack Lee with the Korean Study Group for Behçet’s Disease participated in 
the eMedicine project, where Behçet’s Disease was introduced as a chapter.
  The Patients’ Association of Behçet’s Disease in Korea was founded (www.behcet.co.kr).
  The 1st Seminar for patients with Behçet’s Disease and their family was supported by the 
Korean Study Group for Behçet’s Disease.
  In Ettal, Germany, October 12th-13th, 2000, Professor Sungnack Lee with the Korean 
Study Group for Behçet’s Disease participated in workshop of the International Society for 
Behçet’s Disease with the presentation of a paper. 
2001  A photo-monograph of Behçet’s Disease; A guide to its clinical understanding, with 
147 figures and 121 tables was published by Springer-Verlag, Heidelberg, authored by 





  Proceedings of the 9th and 8th International Conference on Behçet’s Disease were published 
by Professors Dongsik Bang, Eun-So Lee, and Sungnack Lee.
  The 2nd Annual Academic Meeting of the Korean Study Group for Behçet’s Disease was 
held.
  The 2nd Seminar for patients with Behçet’s Disease and their family was supported by the 
Korean Study Group for Behçet’s Disease.
  Behçet’s disease was introduced in the 4th edition of Dermatology text book by Korean 
Dermatological Association by Professors Dongsik Bang and Eun-So Lee.
2002  At the 10th International Conference on Behçet’s Disease, Berlin, Germany, the Korean 
Study Group for Behçet’s Disease participated with papers (oral presentation, posters).
  Development of a clinical activity form for Korean patients with Behçet’s disease was 
presented by Professor Eun-So Lee with the Korean Study Group for Behçet’s Disease.
  The subject “Therapeutic effect of thalidomide through cytokine and chemokine 
regulation in herpes simplex virus-induced Behçet’s disease-like animal model” presented 
by Seonghyang Sohn, Eun-So Lee, Seung Ihm Lee, Youngae Kim, Hyuk Jae Kwon, 
Dongsik Bang, and Sungnack Lee was selected as one of the top 10 abstracts at this 
conference.
  In a special workshop of Behçet’s disease at the 20th World Congress of Dermatology in 
Paris, France, the Korean Study Group for Behçet’s Disease participated as Co-Chairs with 
papers (oral presentation, panel discussion).
  The clinical features of Behçet’s disease in Yougdong districts: Analysis of a cohort 
followed from 1997 to 2001 by Hyun Kyu Chang and Jong Won Kim (J Korean Med Sci 
2002;17:784-9)
  The 3rd Annual Academic Meeting of the Korean Study Group for Behçet’s Disease
  Behçet’s Disease was registered as one of the rare diseases in Korea.
2003  The 3rd Seminar for patients with Behçet’s Disease and their family was supported by the 
Korean Study Group for Behçet’s Disease.
  The 4th Annual Academic Meeting of the Korean Study Group for Behçet’s Disease






  The 3rd List of publications on Behçet’s disease was published by Behçet’s Disease Specialty 
Clinics of Severance Hospital of Yonsei University College of Medicine and Ajou 
University Hospital.
2004  Skin manifestation of Behçet’s Disease was introduced by Professor Dongsik Bang at the 
scientific session on Behçet’s Disease of the 11th Asia Pacific League of Associations for 
Rheumatology (APLAR), Jeju, Korea.
  At the 11th International Conference on Behçet’s Disease, Antalya, Turkey, the Korean 
Study Group for Behçet’s Disease participated with papers (oral presentation, posters). 
  Validation of the classification criteria commonly used in Korea and a modified set of 
preliminary criteria for the Korean Study Group for Behçet’s Disease: A multi-center study 
was done by Hyun Kyu Chang, Shin-Seok Lee, Hyun Joo Bai et al.(Clin Exp Rheumatol 
2004;22(Supple.34);S21-S26)
  Professor Dongsik Bang was elected as a member of the Dermatology, Executive 
committee members of the International Society for Behçet’s Disease.
  The 5th Annual Academic Meeting of the Korean Study Group for Behçet’s Disease
2005  The 4th Seminar for patients with Behçet’s Disease and their family was supported by the 
Korean Study Group for Behçet’s Disease.
  Symposium II Behçet’s Disease was held by the cooperation of the Study Groups of 
Behçet’s Disease in Korea and Japan at the 14th Japan Korea Joint Meeting of Dermatology, 
Kumamoto, Japan.
  The 6th Annual Academic Meeting of the Korean Study Group for Behçet’s Disease
2006  At the 12th International Conference on Behçet’s Disease, Lisbon, Portugal, the Korean 
Study Group for Behçet’s Disease participated with papers (oral presentation, posters).
  Professor Sungnack Lee was elected as President-elect of the International Society for 
Behçet’s Disease.
  The 7th Annual Academic Meeting of the Korean Society for Behçet’s Disease
  At the 7th Annual Meeting of the Korean Society for Behçet’s Disease, December 1st, 2006, 





  The monograph of Behçet’s Disease was published in Korean by Professor Hyun Kyu 
Chang.
  Epidemiology and clinical findings of the Korean Study Group for Behçet’s Disease: 
Statistical analysis of patients in the Jeonnam province from 1997 to 2004 done by Jeong-
Hoon Lee, Sook-Jung Yun, Jee-Bum Lee et al.(Korean J Dermatol 2006;44(5):531-537)
  Professor Dongsik Bang participated as the representative of the dermatologic field 
in a group of experts in Zurich to prepare a report for “the European League against 
Rheumatism (EULAR) recommendations for management of Behçet disease.” This was 
followed by second meeting on January 22th, 2007 at the same site.
2007  At the 21st World Congress of Dermatology in Buenos Aires, Argentina, a poster entitled 
“Effects of vitamin D on expression of toll-like receptors in Behçet’s disease” by E-S Lee, JE 
Do, SY Kwon, S Park was distinguished with a “Certificate of Recognition for Outstanding 
Posters”.
  The 1st Japan and Korea Joint Meeting on Behçet’s Disease was held at Yokohama 
Landmark Tower, Japan.
  The 8th Annual Academic Meeting of the Korean Society for Behçet’s Disease
  Professor Dongsik Bang was elected as the 3rd President of the Korean Society for Behçet’s 
Disease.
  The 5th Seminar for patients with Behçet’s disease and their families was supported by the 
Korean Society for Behçet’s Disease.
2008  Behçet’s disease was introduced in the 5th edition of dermatology text book by Korean 
Dermatological Association by Professor Eun-So Lee and Professor Dongsik Bang.
  At the 13th International Conference on Behçet’s Disease, Pörtschach, Klagenfurt, Austria, 
the Korean Society for Behçet’s Disease participated with papers (oral presentation, 
posters).
  Professors Sungnack Lee, Dongsik Bang, and Eun-So Lee were elected as President, 
Secretary General, and member of Dermatology, Executive committee members of the 
International Society for Behçet’s Disease, respectively.
  The Behçet’s disease quality of life: Reliability and validity of the Korean version done by 





  The 9th Annual Academic Meeting of the Korean Society for Behçet’s Disease
2009  The 6th Seminar for patients with Behçet’s Disease and their family was supported by the 
Korean Society for Behçet’s Disease.
  Development and validation of novel diagnostic criteria for intestinal Behçet’s disease in 
Korean patients with ileocolonic ulcers done by Jae Hee Cheon, Eun Soo Kim, Sung Jae 
Shin et al.(Am J Gastroenterol 2009; 104:2492-2499)
  The 10th Annual Academic Meeting of the Korean Society for Behçet’s Disease.
  The 2nd Korea and Japan Joint Meeting on Behçet’s Disease was held at Seoul, Korea.
  A site visit for the venue, London, of the upcoming 14th International Conference on 
Behçet’s Disease, 2010 was conducted by the Executive Committee members of the 
International Society for Behçet’s Disease. Professors Sungnack Lee, Dongsik Bang, and 
Eun-So Lee participated in this meeting.
2010  Regional distinction for the clinical severity of Behçet’s disease in Korea: four university-
based medical centre studies done by Jung-Yoon Choe, Won-Tae Chung, Sung-Won Lee 
at al.(Clin Exp Rheumatol 2010; 28(Suppl.60):S20-S26)
  At the 14th International Conference on Behçet’s Disease, London, United Kingdom, the 
Korean Society for Behçet’s Disease participated with papers (oral presentation, posters). 
  The meeting of the International Society for Behçet’s Disease was conducted by President 
Sungnack Lee and Secretary General Dongsik Bang.
  As an invited speaker, Professor Eun-Bong Lee introduced the “Perspective of candidate 
gene analysis in Behçet’s disease”.
  The 11th Annual Academic Meeting of the Korean Society for Behçet’s Disease
2011  Professor Dongsik Bang with the Korean Society for Behçet’s Disease organized a 
Symposium of Behçet’s disease at the 22nd World Congress of Dermatology in Seoul, 
Korea.
  The 12th Annual Academic Meeting of the Korean Society for Behçet’s Disease
  The 3rd Japan and Korea Joint Meeting on Behçet’s Disease was held at Yokohama City 





  A site visit for the Yokohama venue of the upcoming 15th International Conference on 
Behçet’s Disease, 2012 was conducted by the Executive Committee members of the 
International Society for Behçet’s Disease. Professors Sungnack Lee, Dongsik Bang, Eun-
So Lee, and Hyeong Gon Yu participated in this meeting.
2012  The Eastern Asia Forum for Behçet’s Disease, organized by Professor Dongsik Bang, was 
held at the 2nd Eastern Asia Dermatology Congress (EADC), Beijing, China.
  At the 15th International Conference on Behçet’s Disease, Yokohama, Japan, the Korean 
Society for Behçet’s Disease participated with papers (oral presentation, posters). The 
meeting of the International Society for Behçet’s Disease was conducted by President 
Sungnack Lee and Secretary General Dongsik Bang.
  The 13th Annual Academic Meeting of the Korean Society for Behçet’s Disease was held.
  The 4th Korea and Japan Joint Meeting on Behçet’s Disease was held at Seoul, Korea. 
2013  The Behçet’s Disease Specialty Clinic, Severance Hospital, Yonsei University College of 
Medicine marked the 30th Anniversary of its opening.
  A monograph of historical aspects of Behçet’s Disease in Korea was published in English.





History of Behçet’s Disease in Korea
The first report of Behçet’s disease in the Korean literature was two cases described by the ophthalmologist 
CR Joo in 1961.(1) The first patient was a 48-year-old woman with recurrent hypopyon together with an 
oral ulcer, genital ulcer, and pustules on the skin. The second patient was a 27-year-old woman who also 
had oral and genital ulcers, as well as inflammatory cells in the anterior chamber of the eye. Four reports of 
Behçet’s disease cases, including one with extreme systemic manifestations, followed in succession.(2) Until 
1983, cases of Behçet’s disease were reported sporadically in the Korean literature.
On November 10th, 1983, the Behçet’s Disease Specialty Clinic—the first of its kind in Korea—opened 
at the Severance Hospital of Yonsei University College of Medicine as a joint effort of the Departments 
of Dermatology, Ophthalmology, and Otorhinolaryngology.(3) This clinic was devoted to collecting 
information on patients with Behçet’s disease scattered nationwide, registering over 1,100 patients over the 5 
years since the opening of the Behçet’s Disease Specialty Clinic. Studies on these registered patients resulted 
in publication of 29 scientific papers in the national and international journals. This year, the clinic will record 
its 30th year in service. At present, over 10,000 patients with Behçet’s disease are registered at this clinic. 
The 4th International Conference on Behçet’s Disease, in London, 5–6, September, 1985, was the first 
Professor Dongsik Bang
President of the Korean Society for Behçet’s Disease
Department of Dermatology and Cutaneous Biology Research Institute 





time data were presented at an International Conference about Behçet’s Disease in Korea. Conference 
participation and presenting data on Behçet’s disease in Korea has continued regularly, including the 15th 
International Conference on Behçet’s Disease, Yokohama, 13–15, July, 2012 . 
On November 15–17th, 1990, genetic, ultrastructural, and immunologic studies of Behçet’s disease in 
Korea were introduced at the Behçet’s Disease Symposium of Asia Pacific League Against Rheumatism 
(APLAR), Seoul, Korea.
At the 50th Annual Meeting of American Academy of Dermatology, held in Dallas in 1991, a poster 
entitled “Clinical Spectrum of Behçet’s Disease” was presented by Professor Dongsik Bang with the research 
team of Behçet’s Disease Specialty Clinic as one of the educational projects, and was recognized with the 
Gold Award for Teaching Value.
On July 11th, 1991, the 1st Korea-Turkey Joint Meeting on Behçet’s Disease was held at Istanbul University, 
where Dr. Hulûsi Behçet was a Professor in the Department of Dermatology. The conference was 
accomplished by the efforts of Professor Türkan Saylan and Sungnack Lee and was continued in a biennial 
format, alternatively in Korea and Turkey, until September 6th, 1999, when it was held in Ankara.
On June 15th, 1992, Professor Sungnack Lee, with the research team of Behçet’s Disease Specialty Clinic, 
organized a workshop on Behçet’s disease at the 18th World Congress of Dermatology in New York.
On June 1st, 1994, a Behçet’s Disease Specialty Clinic was opened at Ajou University Hospital.
In 1994, Behçet’s disease was introduced in the 3rd edition of Dermatology text book by Korean 
Dermatological Association by Professor Dongsik Bang and Professor Sungnack Lee.
In July 1995, and September 1998, the Behçet’s Disease Specialty Clinics of the Severance Hospital of the 
Yonsei University College of Medicine and Ajou University Hospital published the first and second editions 
of the Reference Index on Behçet’s disease and distributed these to researchers and institutions around the 
world to provide invaluable assistance to all the dedicated researchers of Behçet’s disease. A total of 4591 
papers were put together to make up the second edition. 
On February 28th, 1996, Behçet’s Disease was introduced by Professors Sungnack Lee, Dongsik Bang, and 
Eun-So Lee from the Clinical Dermatology (Chief Editor; Dr. Joseph Demis).(4)
On January 20th, 1998, the monograph of Behçet’s Disease was published in Korean by Professors Dongsik 
Bang, Eun-So Lee, and Sungnack Lee.(5)
On March 4th, 1999, a meeting was held regarding the organization of the Korean Academic Society for 





was appointed as the 1st President of the Korean Study Group for Behçet’s Disease.
On October 2nd, 1999, the 1st Annual Academic Meeting of the Korean Study Group for Behçet’s Disease 
was held and included invited lecturers Dr. Colin G. Barnes from the UK, who was the convener of the 
International Study Group for Behçet’s Disease, and Professor Shigeaki Ohno from Japan, who was the 
President of the Behçet’s Disease Research Committee of Japan, and Ministry of Health and Welfare, Japan.
Since then, and most recently at the 13th Annual Meeting of the Korean Society for Behçet’s Disease in 
November 30th, 2012, the meetings have been held regularly every year.
Since the 7th Annual Meeting of the Korean Society for Behçet’s Disease, on December 1st, 2006, the name 
of the meeting was changed from ’Study Group’ to ’Society’.
At present, the Korean Society for Behçet’s Disease has 180 regular members.
On December 3rd, 1999, a link between Herpes virus and Behçet’s Disease was introduced by Professor 
Dongsik Bang at the 7th National Congress of Behçet’s Disease, Istanbul, Turkey.
The 9th International Conference on Behçet’s Disease was held for three days from May 27th to 29th, 
2000, in Seoul, Korea. The 1st International Conference on Behçet’s Disease opened in the Far East Asian 
region as the Tokyo conference in 1981. The Seoul conference was the second International Conference 
on Behçet’s Disease in this region and was held 19 years after the Tokyo conference. The 9th International 
Conference on Behcet’s Disease was organized by Professor Sungnack Lee as the President of the Organizing 
Committee and Professor Dongsik Bang as the Secretary General, with the assistance of the Department of 
Dermatology and the Behcet’s Disease Specialty Clinic at Severance Hospital of Yonsei University College 
of Medicine, and Behcet’s Disease Specialty Clinic of Ajou University Hospital. The congress was supported 
and sponsored by the Korean Study Group for Behçet’s Disease, the Korean Dermatological Association, 
the Korean Rheumatism Association, the Korean Ophthalmologic Society, the Korean Academy of 
Medical Sciences, and the Korean Medical Association. Although Korea, as the host country, was located 
at a far distance geographically from Europe, America, the Middle East, and the Mediterranean region, 
the conference drew more than 250 participants from 23 countries. A total of 175 papers (100 poster 
presentations, 72 oral presentations, 3 plenary lectures) were presented, along with active discussions. The 
most meaningful event to occur during the conference was the official foundation of the International 
Society for Behçet’s Disease, after having held conferences without a formal society since 1964. During the 
congress, all representatives of the former International Study Group on Behçet’s Disease held an election 





society. Dr. Colin G. Barnes was elected as President, Dr. Sungnack Lee as Vice-President, Dr. Hasan Yazici 
as President-Elect/Secretary, and Dr. Dorian Haskard as Treasurer. Professors Nihat Dilsen, George Ehrlich, 
Thomas Lehner, and Dr. J. Desmond O’Duffy were nominated as Lifetime Honorary Presidents of the 
International Society for Behçet’s Disease. The 2-year membership fee of the new society was US$100.
The Proceedings of the 9th and 8th International Conference on Behçet’s Disease were published by 
Professors Dongsik Bang, Eun-So Lee, and Sungnack Lee.(6)
The first multicenter study on an epidemiologic and clinical survey of Behçet’s disease in Korea was 
conducted by the Korean Study Group for Behçet’s Disease in 2000. Of 3,497 patients, the sex ratio was 1:1.75, 
with a female predominance, and median age of onset was 33 years (range 1-75) with higher frequency of 
ocular lesions and lower positivity of pathergy test.(7) 
In 2000, Professor Sungnack Lee, with the Korean Study Group for Behçet’s Disease, participated in the 
eMedicine project where Behçet’s Disease was introduced as a chapter and this spread information about 
BD far and wide in the world.
On July 22nd, 2000, the Patients Association of Behçet’s Disease in Korea was founded. A Seminar for 
patients and their families has been held biennially since then by the Korean Society for Behçet’s Disease. The 
name of the association is the Korea Behçet Patron, which has a website at www.behcet.co.kr and regularly 
publishes a newsletter. The first international convention for patients with Silk Road Disease (Behçet’s 
Disease), hosted by Professor Shigeaki Ohno, Japan, was held on May 19-22, 2000, in Japan. Its emphasis 
was on the idea that doctors and patients with their families should work hard together to overcome this 
rare, intractable disease.
In Ettal, Germany, on October 12th–13th, 2000, Professor Sungnack Lee with the Korean Study Group for 
Behçet’s Disease participated in a workshop of the International Society for Behçet’s Disease by presenting a 
paper. 
In January 2001, Professor Sungnack Lee, with the Korean Study Group for Behçet’s Disease, published 
’Behçet’s Disease: a guide to its clinical understanding with 147 figures and 121 tables.’ The volume was 
published by Springer-Verlag, Heidelberg in a photo-monograph style that was easy for clinicians to 
understand.(8)
In 2001, Behçet’s disease was introduced in the 4th edition of Dermatology text book by Korean 
Dermatological Association by Professor Eun-So Lee and Professor Dongsik Bang.





support for medical expenses by the government. The prevalence of Behçet’s disease in Korea became 
known due to the registration system, which showed that the numbers of patients with Behçet’s disease 
registered by the National Health Insurance Corporation of Korea were increasing. As of 2006, 15,554 
patients with Behçet’s Disease (5,499 males and 10,055 females, 30.2/100,000 people) were registered with 
the Center for Genetic & Rare Diseases (Korea Centers for Disease Control and Prevention, Seoul, Korea).(9)
On June 27th–29th, 2002, Professor Eun-So Lee with the Korean Study Group for Behçet’s Disease 
presented “Development of clinical activity form for Korean patients with Behçet’s disease” at the 10th 
International Conference on Behçet’s Disease, held in Berlin. The subject “Therapeutic effect of Thalidomide 
through cytokine and chemokine regulation in herpes simplex virus-induced Behçet’s disease-like animal 
model” presented by Seonghyang Sohn, Eun-So Lee, Seung Ihm Lee, Youngae Kim, Hyuk Jae Kwon, 
Dongsik Bang, and Sungnack Lee was selected as one of the Top 10 abstracts at this conference.
On November 8th, 2003, Professor Yong Il Kim was elected as the 2nd President of the Korean Study Group 
for Behçet’s Disease at the 4th Annual Academic Meeting of the Korean Study Group for Behçet’s Disease.
On September 11th, 2004, “Skin Manifestation of Behçet’s Disease” was introduced by Professor 
Dongsik Bang at the scientific session on Behçet’s disease at the 11th Asia Pacific League of Associations for 
Rheumatology (APLAR), Jeju, Korea.
On October 30th, 2004, Professor Dongsik Bang was elected as a member of the Dermatology, Executive 
committee members of the International Society for Behçet’s Disease.
On November 4th, 2005, Symposium II Behçet’s Disease was held in cooperation with the Study Groups of 
Behçet’s Disease in Korea and Japan at the 14th Japan Korea Joint Meeting of Dermatology, Kumamoto, Japan.
On September 23th, 2006, Professor Sungnack Lee was appointed as President elect of the International 
Society for Behçet’s Disease at the 12th International Conference on Behçet’s Disease, Lisbon.
On October 9th, 2006, Professor Dongsik Bang participated in a group of experts to prepare a report for “the 
European League against Rheumatism (EULAR) recommendations for management of Behçet disease” as 
the representative from a dermatologic field. The meeting was held in Zurich and was followed by second 
meeting in January 22th, 2007 at the same site.(10, 11)
On July 20th, 2007, the 1st Japan-Korea Joint Meeting on Behçet’s Disease was held at Yokohama Landmark 
Tower, Japan. It was accomplished by the efforts of Professor Yoshiaki Ishigatsubo, Yokohama City University 
Graduate School of Medicine, and Professor Yong Il Kim as the 2nd President of the Korean Society for 





Yu, Eun-So Lee, Seonghyang Sohn, and Joo Young Roh participated with the presentation of papers.
On September 30th – October 5th, 2007 in Buenos Aires, Argentina, a poster entitled “Effects of vitamin D 
on expression of toll-like receptors in Behçet’s disease” by E-S Lee, JE Do, SY Kwon, S Park was distinguished at 
the 21st World Congress of Dermatology with a “Certificate of Recognition for Outstanding Posters”.
On November 30th, 2007, Professor Dongsik Bang was elected as the 3rd President of the Korean Society 
for Behçet’s Disease at the 8th Annual Academic Meeting of the Korean Society for Behçet’s Disease.
In 2008, Behçet’s disease was introduced in the 5th edition of Dermatology text book by Korean 
Dermatological Association by Professor Eun-So Lee and Professor Dongsik Bang.
On May 26th, 2008, Professors Sungnack Lee, Dongsik Bang, and Eun-So Lee were elected as President, 
Secretary General, and member of the Dermatology, Executive committee members of the International 
Society for Behçet’s Disease, respectively.
In addition, members of the Korean Society for Behçet’s Disease have contributed to the International 
Society for Behçet’s Disease as council members and conveners of the study group.
On November 13th, 2009, the 2nd Korea-Japan Joint Meeting on Behçet’s Disease was held at Seoul, Korea 
by the efforts of Professor Yoshiaki Ishigatsubo, Yokohama City University Graduate School of Medicine, 
and Professor Dongsik Bang as the 3rd President of the Korean Society for Behçet’s Disease.
On December 4th, 2009, a site visit was conducted for London, venue of the upcoming 14th International 
Conference on Behçet’s Disease, 2010 by the Executive Committee members of the International Society 
for Behçet’s Disease. Professors Sungnack Lee, Dongsik Bang, and Eun-So Lee participated in this meeting. 
On July 8th–10th, 2010, the 14th International Conference on Behçet’s Disease was held in London, United 
Kingdom. The business meetings of International Society for Behçet’s Disease were conducted by President 
Sungnack Lee and Secretary General Dongsik Bang. As an invited speaker, Professor Eun-Bong Lee, Seoul 
National University College of Medicine, introduced “Perspective of candidate gene analysis in Behçet’s 
disease.”
On May 28th, 2011, Professor Dongsik Bang with the Korean Society for Behçet’s Disease organized a 
Symposium on Behçet’s Disease at the 22nd World Congress of Dermatology in Seoul, Korea.
On December 16th, 2011, the 3rd Japan-Korea Joint Meeting on Behçet’s Disease was held at Yokohama 
City University Graduate School of Medicine, Japan with the cooperation of Professors Yoshiaki Ishigatsubo 
and Dongsik Bang. At the same time, a site visit was conducted for Yokohama, the venue of the upcoming 





International Society for Behçet’s Disease. Professors Sungnack Lee, Dongsik Bang, Eun-So Lee, and Hyeong 
Gon Yu participated in this meeting.
On June 14th, 2012, the Eastern Asia Forum for Behçet’s Disease was held with the organization of 
Professor Dongsik Bang at the 2nd Eastern Asia Dermatology Congress (EADC), Beijing, June 13th–15th, 
2012. This meeting clarified the clinical features of Behçet’s Disease in the Far East countries including 
China, Korea, and Japan. 
On July 13th–15th, 2012, the 15th International Conference on Behçet’s Disease was held in Yokohama, 
Japan. The business meetings of International Society for Behçet’s Disease were conducted by President 
Sungnack Lee and Secretary General Dongsik Bang.
On November 10th, 2013, the Behçet’s Disease Specialty Clinic, Severance Hospital, Yonsei University 
College of Medicine marked the 30th Anniversary of its opening.
A monograph of the historical aspects of Behçet’s Disease in Korea was published in English by Professor 
Dongsik Bang and editorial staff.
On November 22nd, 2013, the 14th Annual Academic Meeting of the Korean Society for Behçet’s Disease 
will be held.
The effort to overcome this rare and recalcitrant Behçet’s disease has benefited from the contributions 
of the Korean Society for Behçet’s Disease in its investigations in several fields, including animal models, 
the role of HSV, diagnostic criteria of gastrointestinal Behçet’s Disease, anti-endothelial cell antibodies, 
epidemiological surveys, and immunogenetics, etc., through the cooperation with the International Society 
for Behçet’s Disease.
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The Korean Society for Behçet’s Disease
1) History of Foundation
On March 4, 1999, 15 doctors who were interested in Behçet’s disease held a meeting regarding the 
organization of the Korean Academic Society for Behçet’s Disease. The meeting was held in the Seminar 
room, 3rd floor, Daewoo Foundation Building, Seoul, Korea. Participants included Professors Young 
Mo Kang (Rheumatology, Kyungpook National University School of Medicine), Chong-Youl Kim (Oral 
Medicine, College of Dentistry, Yonsei University), Soo Nam Kim (Dermatology, College of Medicine, 
Korea University), Yong Il Kim (Pathology, Seoul National University College of Medicine), Won Ho 
Kim (Internal Medicine, Yonsei University College of Medicine), Hong Bok Kim (Ophthalmology, 
Yonsei University College of Medicine), Dong Ki Nam (Hematology Oncology, Ajou University School 
of Medicine), Seonghyang Sohn (Cell Biology, Ajou University Institute for Medical Sciences), Kwang 
Hoon Lee (Dermatology, Yonsei University College of Medicine), Soo Kon Lee (Rheumatology, Yonsei 
University College of Medicine), Eun-So Lee (Dermatology, Ajou University School of Medicine), Dongsik 
Bang (Dermatology, Yonsei University College of Medicine), Sungnack Lee (Dermatology, Ajou University 
School of Medicine), and two doctors from the Catholic University of Korea. Although twenty doctors were 
not able to join the meeting, they were accepted as members in the meeting regarding the organization of the 
Korean Academic Society for Behçet’s Disease. For the introduction, Professor Sungnack Lee explained the 
necessity of the organization of the Korean Academic Society for Behçet’s Disease—including the upcoming 
9th International Conference of Behçet’s Disease in 2000, which was decided at the 7th International 





In this meeting, a tentative constitution was made, and the meeting was named the Korean Study Group 
for Behçet’s Disease. The initial membership fee was ₩10,000. An inaugural assembly meeting and the 1st 
Academic Meeting of the Korean Study Group for Behçet’s Disease was planned  for June or October 1999, 
wherein the president had been elected. For the preparation of the meeting, Professor Sungnack Lee was 





2) Chronological Organization and Introduction of the Presidents
1st President (1999-2003) and Executive Members
Sungnack Lee, Dr. med. habil.
Education:
1958 - 1959 German Language School, Heidelberg, Germany
1959 - 1962  Pre-Medical School, University of Marburg, Marburg, Germany
1962 - 1966 Medical School, University of Munich, Munich, Germany  
1969 - 1972  Residency in Department of Dermatology (Prof. Theodor Nasemann), University of 
Frankfurt, Germany
1975  The degree of Habilitation, University of Frankfurt, Germany
2011 -  Ph.D. Course in the Art History, Graduate School of Myoung-ji University, Seoul
Academic Appointments: 
1975 - 1990 Professor of Dermatology, Yonsei University College of Medicine, Seoul
1985 - 1987 Director for Planning & Coordination Office, Yonsei University Medical Center
1990 Professor of Dermatology, Ajou University School of Medicine, Suwon, Korea
1990 - 1994 Dean, Ajou University School of Medicine
1994 - 1998  Vice President for Medical Affairs of Ajou University & Director of Ajou University 
Medical Center
1998 - 2000 Vice President for Medical Affairs of Ajou University  
1999 - 2000 Director, Korean Institute of Hospital Management, Seoul





2004 - 2008  President, Gachon University of Medicine and Science, Incheon
2008 -  Honorary President, Gachon University
Editorial Boards:
1. Editor, Clinics in Dermatology (Philadelphia) 
2. Editor, The American Journal of Dermatopathology 
3. Editor, The Journal of the American Academy of Dermatology 
4. Editor, Der Hautarzt, Germany
5. Member of the International Advisory Committee Board, Archives of Dermatology, U.S.A.
Social Activities:
1986 – 2004 Council Member of the Asian Dermatological Association, Hong Kong
1997 - 1999 President, The Korean Society of Investigative Dermatology
1999 - 2003  President, The Korean Society for Behçet’s Disease
2000 - 2009  Vice President, The Korean-German Association
2000 - 2003 President, The Korean Society of Medical Education
2000 - 2008 Vice President, International Society for Behçet’s Disease (ISBD)
2008 - 2012  President, International Society for Behçet’s Disease (ISBD)
2004 - 2009   Vice President, The Korean Membership Society of the National Museum of 
Contemporary Art, Korea
2011 -   President, The Korean Membership Society of the National Museum of Contemporary 
Art, Korea
2009 - 2013  Chairman, Organizing Committee of KIAF (Korea International Art Fair)
Executive members (1999-2003)
Secretary General  Dongsik Bang (2002 - 2003; Department of Dermatology and Cutaneous Biology 
Research Institute, Yonsei University College of Medicine, Seoul)
Scientific Affairs  Yeong Wook Song (2002 - 2003; Department of Internal Medicine, Division of 






Treasurer  Eun-So Lee (2002 - 2003; Department of Dermatology, Ajou University School of 
Medicine, Suwon)
Auditor  Kyung Sook Park (2002 - 2003; Department of Biology, College of Natural 





2nd President (2003-2007) and Executive Members
Yong Il Kim, M.D., Ph.D.
Education and training
1957 - 1961  M.D. Seoul National University, College of Medicine
1961 - 1963 M.S. Seoul National University, Graduate School of Medicine  
1963 - 1967 Ph.D. Seoul National University, Graduate School of Medicine
Career
1967. 9  Resident, Department of Pathology, University of Cincinnati, Ohio, USA
1969 Instructor, Department of Pathology, University of Cincinnati, Ohio, USA
1975 Director, Department of Pathology, Seoul National University Hospital
1978 - 2000   Professor, Department of Pathology, Seoul National University Hospital, College of 
Medicine
1978  Director of Academic & Student affairs, Seoul National University College of Medicine
1980 Associate director, Seoul National University College of Medicine
1988  Associate Dean of Student & Academic affairs, Seoul National University College of 
Medicine; Director of National Teacher Training Center, Korea
1978 - 2000 Professor of Department of Pathology, Seoul National University, College of Medicine
1988 - 1992 Chairman of Department of Pathology, Seoul National University Hospital
1992 - 1995 Vice president, Seoul National University Hospital
1994 - 1995 President, The Korean Society of Pathologists
1994 - 1995 President, The Korean Society of Gastroenterology





1995 - 1997 President, The Korean Society of Medical Education, AMEWPR
1995 -      Editorial member, Pathology International
1996 - 1998 President, WHO-Association for Medical Education in the Western Pacific Region
1997 - 2000 Consultant, Executive Committee of the World Federation for Medical Education
1998 -      Member, The National Academy of Sciences, Republic of Korea
2000 - 2004 President, Gachon University of Medicine and Science
2003 - 2007 President, The Korean Society for Behçet’s Disease
2004 -      Honorary Professor, Seoul National University
2004 - 2008 President and Honorary President, Eulji University 
2009 - 2012 Honorary President, Gachon University of Medicine and Science
Executive members (2003-2007)
Secretary General  Dongsik Bang (2003 - 2007; Department of Dermatology and Cutaneous Biology 
Research Institute, Yonsei University College of Medicine, Seoul)
Scientific Affairs  Bin Yoo (2003 - 2007; Division of Rheumatology, Department of Internal 
Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul)
Treasurer  Eun-So Lee (2003 - 2007; Department of Dermatology, Ajou University School of 
Medicine, Suwon)
Public Relations   Hyeong Gon Yu (2005 - 2007; Department of Ophthalmology, Seoul National 
University Hospital, Seoul National University College of Medicine, Seoul)
Auditor  Yeong Wook Song (2003 - 2007; Department of Internal Medicine, Division of 






3rd President (2007-present) and Executive Members
Dongsik Bang, M.D., Ph.D.
Education:
1976 Bachelor of Medicine, Yonsei University College of Medicine 
1979 - 1980 Internship, Severance Hospital, Yonsei Medical Center
1980 - 1983 Residency, Department of Dermatology, Severance Hospital, Yonsei Medical Center
1982  Dermatology, Master of Medicine, Graduate School of Yonsei University
1985 Dermatology, Ph.D., Graduate School of Yonsei University  
1985 - 1986  Visiting Fellow, Department of Dermatology, Kawasaki Medical School, Juntendo 
University School of Medicine, Japan
Academic Appointments:
1984 - 1987 Instructor, Department of Dermatology, Yonsei University College of Medicine
1987 - 1990  Assistant professor, Chairman, Department of Dermatology, Yonsei University Wonju 
College of Medicine
1990 - 1993 Assistant professor, Department of Dermatology, Yonsei University College of Medicine
1993 - 1998  Associate professor, Department of Dermatology, Yonsei University College of Medicine
1998 - Professor, Department of Dermatology, Yonsei University College of Medicine
1996 - 2002 Chairman, Department of Dermatology, Yonsei University College of Medicine
2000 - 2004 Head of Cutaneous Biology Research Institute, Yonsei University College of Medicine
2002 - 2004 Associate Dean of Yonsei University College of Medicine






2002 -  Editorial Board of Clinical Experimental Rheumatology: Behçet’s disease and other 
autoinflammatory conditions 
2007 - 2012 Editor in Chief of Korean Dermatological Association 
Social Activities:
1997 - 1999 Chairman of Board of Director, Korean Society for Investigative Dermatology
1999 - 2001  Executive member (Scientific Affairs) of Board of Director, Korean Dermatological 
Association
1999 - 2007  Secretary General, Korean Study Group for Behçet’s Disease
2000  Secretary General of Organizing Committee, The 9th International Conference on 
Behçet’s Disease
2000 - 2004 Board of Council, International Society for Behçet’s Disease
2001 - 2011 Member of Board of Director, Korean Dermatological Association 
2004 - 2012   Executive member (Secretary General) of Board of Council, International Society for 
Behçet’s Disease
2007 -   President, The Korean Society for Behçet’s Disease
2011 - 2012  President, The Korean Society for Investigative Dermatology
2012 -  Board of Council, International Society for Behçet’s Disease
Awards:
1991  Gold Award (The 50th American Academy of Dermatology, Dallas, Tx) educational 
poster entitled “Clinical Spectrum of Behçet’s disease” 
1992 Scientific Award, The Korean Federation of Science and Technology Societies
2011 Stiefel Investigative Award, The Korean Dermatological Association






Secretary General:  Eun-So Lee (2007 - present; Department of Dermatology, Ajou University School 
of Medicine, Suwon)
Scientific Affairs:  Hyeong Gon Yu (2007 - present; Department of Ophthalmology, Seoul National 
University Hospital, Seoul National University College of Medicine, Seoul)
Treasurer:   Joo Young Roh (2007 - present; Department of Dermatology, Gachon University, 
School of Medicine, Incheon)
Public Relations:  Eun Bong Lee (2007 - 2011; Division of Rheumatology, Department of Internal 
Medicine, Seoul National University College of Medicine, Seoul)
  Chang-Keun Lee (2011 - present; Division of Rheumatology, Department of 
Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, 
Seoul)
Auditor:   Bin Yoo (2007 - 2011; Division of Rheumatology, Department of Internal 
Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul)
  Eun Bong Lee (2011 - present; Division of Rheumatology, Department of Internal 





3) Program of Academic Meetings with Invited Guests
At A Glance
Meeting Date Venue President
1st 1999.10.02 Sangnam Institute of Management, Yonsei University, Seoul Sungnack Lee
2nd 2001.10.09








Cancer Research Institute 2nd floor Lee Kun-Hee Hall, Seoul 
National University Hospital, Seoul
Sungnack Lee
5th 2004.11.26
East Building 4th floor small auditorium & exhibit hall, Asan 
Medical Center, Seoul
Yong Il Kim 
6th 2005.11.24
East Building 4th floor small auditorium & exhibit hall, Asan 
Medical Center, Seoul
Yong Il Kim 
7th 2006.12.01
East Building 4th floor small auditorium & exhibit hall, Asan 
Medical Center, Seoul
Yong Il Kim 
8th 2007.11.30 Research Building I Auditorium, Asan Medical Center, Seoul Yong Il Kim 
9th 2008.11.14
Cancer Research Institute 2nd floor Lee Kun-Hee Hall, Seoul 
National University Hospital, Seoul
Dongsik Bang
10th 2009.11.13




Cancer Research Institute 2nd floor Lee Kun-Hee Hall, Seoul 
National University Hospital, Seoul
Dongsik Bang
12th 2011.11.18
Cancer Research Institute 2nd floor Lee Kun-Hee Hall, Seoul 
National University Hospital, Seoul
Dongsik Bang
13th 2012.11.30
Cancer Research Institute 2nd floor Lee Kun-Hee Hall, Seoul 
National University Hospital, Seoul
Dongsik Bang
14th 2013.11.22
NEWILHAN Memorial Hall of Avison Biomedical Research 






1st Academic Meeting of the Korean Society for Behçet’s Disease
October 2, 1999
Sangnam Institute of Management,
Yonsei University, Seoul, Korea
Invited speakers
Colin G. Barnes
Convenor, International Study Group for Behçet’s Disease
Honorary Senior Lecturer, Rheumatology, The London Hospital Medical College, University of 
London, London, U.K.
Shigeaki Ohno
Professor and Chairman, Department of Ophthalmology, Yokohama City 
University of Medicine, Yokohama, Kanagawa, Japan
President, Behçet’s Disease Research Committee of Japan, Ministry of 
Health and Welfare, Japan
Special lecture I
Diagnosis and classification of Behçet’s syndrome
Colin G. Barnes
Special lecture II
Molecular genetics of Behçet’s disease
Shigeaki Ohno
Free communication






Abstract cover of the 1st Academic Meeting of 
the Korean Society for Behçet’s Disease
Group photo of the 1st Academic Meeting of the Korean Society for Behçet’s Disease
2. Behçet’s disease in Korea
Dongsik Bang






2nd Academic Meeting of the Korean Society for Behçet’s Disease
October 9, 2001
Biomedical Research Institute Auditorium, 
Seoul National University Hospital, Seoul, Korea
Invited speaker
Mitsuhiro Takeno 
Associate Professor, Department of Immunology and Medicine,                   
St. Marianna University of School of Medicine, Kawasaki, Japan
Special lecture I
Innate and acquired immunity in Behçet’s disease
Mitsuhiro Takeno 
Special lecture II
Result of 1st multicenter study about Behçet’s disease in Korea
Ju Hee Lee
Free communication I 
1.  Thalidomide regulated several cytokines and chemokine MIP-1α in herpes simplex virus-induced 
Behçet’s disease animal model
Seonghyang Sohn, Eun-So Lee, Seung Ihm Lee, Young Ae Kim, Dongsik Bang, Sungnack Lee
2. Survey and validation of the criteria for Behçet’s disease recently used in Korea: A suggested preliminary criteria
Hyun Kyu Chang, Seung Yong Kim, Yunseok Kim, Kyeong Soo Cheon
3. The clinical features of Behçet’s disease in Yongdong districts
Hyun Kyu Chang
4. The clinical significance of a pathergy reaction in patients with Behçet’s disease





5.  The comparison between Behçet’s disease and spondyloarthropathy: Is Behçet’s disease a part of 
seronegative spondyloarthritides?
Hyun Kyu Chang, Seung Mun Jung, Deok Hee Lee, Kyeong Soo Cheon, Young Joon Choi,            
Seung Ki Baek, Eun Hee Cho
6. Postoperative immunosuppressive therapy in patients of vascular Behçet’s disease
Yong-Beom Park, Jun-Won Chung, Won-Heum Shim, Soo Kon Lee
Free communication II
1. TNFA, TNFB, IL4, IL1, ILRA genes in Behçet’s disease
Jee Won Mok, Dongsik Bang, Eun Hee Kim, Eun-So Lee, Sungnack Lee, Kyung Sook Park
2. A case of extranodal NK/T-cell lymphoma presenting Behçet’s disease like manifestation
Nam Jin Kim, Hye Ran Lee, Chan-Hee Lee, Sung-Hun Han, Dongwook Kim, Seong Hye Park,           
Yun-Woo Lee
3. Coagulation parameters and plasma total homocysteine levels in Behçet’s disease
Yun Jong Lee, Jong In Yang, Donghyuk Sheen, Young-Mi Choi, Eun Bong Lee, Sang-Woon Choi, 
Yeong Wook Song
4. A case of Behçet’s disease in a child
Gwang Cheon Jang, Dong Soo Kim
5.  Clinical features of patients with Behçet’s disease and epididymitis
Young Hun Cho, Dongsik Bang, Eun-So Lee, Sungnack Lee
6.  Influence of sex on patients with Behçet’s disease in Korea
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3rd Academic Meeting of the Korean Society for Behçet’s Disease
September 5, 2002
Biomedical Research Institute Auditorium, 
Seoul National University Hospital, Seoul, Korea
Invited speakers
Koh-Hei Sonoda
Assistant Professor, Department of Ophthalmology, Kyushu University, 
Japan
Hyo Jong Kim
Professor, Division of Gastroenterology, Department of Internal Medicine, Kyung Hee University 
School of Medicine, Korea
Special lecture I
The current manifestations and therapies of ocular Behçet’s disease in Japan
Koh-Hei Sonoda
Special lecture II
Treatment with adacolum in ulcerative colitis: Experience in Korea
Hyo Jong Kim
Free comuunication
1. Study about the disease activity in Behçet’s disease
Eun-So Lee
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4th Academic Meeting of the Korean Society for Behçet’s Disease
November 8, 2003
Cancer Research Institute 2nd floor Lee Kun-Hee Hall, 
Seoul National University Hospital, Seoul, Korea
Invited speaker
Rafi Haner Direskeneli
Professor of Rheumatology, Head, Department of Rheumatology,             
Marmara University Medical School, Istanbul, Turkey
Special lecture
Behçet’s disease: From innate to adaptive immunity
Rafi Haner Direskeneli
Free communication 
1. Epidemiology and clinical symptoms
1) The prevalence of atopy and atopic disease in Behçet’s disease
Hyun Kyu Chang, Shin-Seok Lee, Yoon Woo Lee, Bo Young Yoon
2) Behçet’s disease and thyroid disorders 
Sung Bin Cho, Ju Hee Lee, Kwang Hoon Lee, Dongsik Bang, Eun-So Lee, Sungnack Lee
3) Fibromyalgia in Behçet’s disease
Shin-Seok Lee, Seo-Na Hong, Hyun Kyu Chang
4) Epstein-Barr virus related hemophagocytic lymphohistiocytosis in a patient with Behçet’s disease 
Seung-Hwan Lee, Sung Hwan Park, Younsuck Koh, Sang-Hyon Kim, Sung Dong Kim, Hae-Rim 
Kim, Chong-Hyeon Yoon, Sang-Heon Lee, Ho-Youn Kim
2. Diagnosis and treatment





criteria for Behçet’s disease: a multi-center study
Hyun Kyu Chang, Shin-Seok Lee, Yoon Woo Lee, Bo Young Yoon, Chan-Hee Lee, Young Ho Lee, 
Kwan Kyu Song, Won Tae Chung, Sung Won Lee, Jung-yoon Choe, Chaekee Kim, Dae Kook Chang
2)  Expression of anti-saccharomyces cerevisiae antibody (ASCA) in Behçet’s disease colitis and its 
relation to clinical progress 
Won Ho Kim, Chang Hwan Choi, Sang Kil Lee, Byeong Chang Kim, Tae Il Kim
3) Study of the expression of antinuclear antibody in Behçet’s disease 
Eun Young Chun, Sang Gun Park, Young Hun Cho, Ju Hee Lee, Kwang Hoon Lee, Dongsik Bang, 
Eun-So Lee, Sungnack Lee
4) The effect of intravitreous triamcinolone injection in Behçet uveitis 
Sung Chul Lee
3. Immunology
1)  The proportion of NK cell and NK-like T cell in the intraocular inflammatory infiltrates of Behçet’s 
disease patients 
Hyeong Gon Yu, Hum Chung
2)  The role of chemokines in the pathogenesis of Behçet’s disease (part 1) – focusing on the effect of 
treatment 
Jinhee Heo, Seonghyang Sohn, Sungnack Lee, Eun-So Lee
3)  pCIN-mIL-4 DNA vector is expressed to mRNA and protein and improve the Behçet’s disease-like 
symptoms in herpes simplex virus-induced mouse model
Seonghyang Sohn, Seung Ihm Lee, Hyuk Jae Kwon, Eun-So Lee, Byung Chul Yang, Dongsik Bang, 
Sungnack Lee
4. Genetics
1) IL-8 and its receptor polymorphisms in Korean patients with Behçet’s disease
Eun Bong Lee, Jeongyeon Kim, Kichul Shin, Young Deok Bae, Hyo Jin Choi, Jung Chan Lee,  
Yeong Wook Song





Hyun Kyu Chang, Sangbum Park, Sangman Han, Youn Hyoung Nam, Won Cheoul Jang,               
Shin-Seok Lee
3)  Lack of association between angiotensin-converting enzyme gene polymorphism and Behçet’s disease
Hyun Kyu Chang, Jeong Uk Kim, Shin-Seok Lee, Dae Hyun Yoo
4)  Endothelial nitric oxide synthase gene polymorphisms in Behçet’s disease and rheumatic disease 
with vasculitis
Hyun Kyu Chang, Jeong Uk Kim, Shin-Seok Lee, Sung Won Lee, Won-Tae Chung
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5th Academic Meeting of the Korean Society for Behçet’s Disease
November 26, 2004
East Building 4th floor small auditorium & exhibit hall, 
Asan Medical Center, Seoul, Korea
Invited speaker
Dong Yi
Professor of Medicine, Department of Rheumatology and Clinical 
Immunology, Peking Union Medical College Hospital, Beijing, China
President, Beijing Rheumatology Association
Editor-in-Chief, Chinese Journal of Rheumatology
Special lecture
Behçet’s disease in China
Dong Yi
Educational lectures I




Ocular symptoms of Behçet’s disease
Sung Chul Lee
Educational lectures III







Gastrointestinal symptoms of Behçet’s disease
Suk-Kyun Yang
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6th Academic Meeting of the Korean Society for Behçet’s Disease
November 24, 2005
East Building 4th floor small auditorium & exhibit hall, 
Asan Medical Center, Seoul, Korea
Invited speaker
Samir Helmy Assaad-Khalil
Professor of Internal Medicine, Unit of Diabetes, Metabolism and 
Immunology, Alexandra Faculty of Medicine, Alexandra University, Egypt
Special lecture
Behçet’s disease in Egypt
Samir Helmy Assaad-Khalil
Free Communication
1. Epidemiology and clinical symptoms
1)  Pancytopenia secondary to administration of oral immunosuppressants and colchicine in patients 
with Behçet’s disease: Report of two cases
Kyu-yeop Lee, Jae Yong Chang, Dongsik Bang
2) Manifestation and clinical outcome in Behçet’s disease with cardiovascular involvement
Seong-Su Nah, Yong-Gil Kim, Min-wook So, Chang-Keun Lee, Bin Yoo
3)  Epidemiology and clinical findings of Behçet’s disease: Statistical analysis of patients in the Jeonnam 
province from 1997 to 2004
Jeong Hoon Lee, Sook Jung Yun, Jee Bum Lee, Seong Jin Kim, Young Ho Won, Seung Chul Lee
2. Immunology and genetics
1)  Tumor necrosis factor alpha interfering RNA decreases herpes simplex virus-induced inflammation 





Seonghyang Sohn, Bunsoon Choi, Yun-Jung Hwang, Hyuk Jae Kwon, Eun-So Lee, Kyung Sook 
Park, Dongsik Bang, Sungnack Lee
2) Galectin-3 and galectin-3 binding protein in Behçet’s disease
Yun Jong Lee, Seong Wook Kang, Jeong Jin Park, Young Deok Bae, Eun Young Lee, Eun Bong 
Lee, Yeong Wook Song
3) Decreased HLA-G expression in sera from patients with Behçet’s disease
Sung-il In, Jin Hee Heo, Jin Sun Choi, Kyung Sook Park, Eun-So Lee
3. Immunology and pathology
1)  Mannose binding lectin gene-2 polymorphisms and serum mannose binding lectin level in Behçet’s 
disease
Churl Hyun Im, Eun Ha Kang, Eun Young Lee, Yun Jong Lee, Kyung Sook Park, Yeong Wook Song
2)  The cross-reactivity of anti human α-enolase antibody to Streptococcus sanguinis antigens and other 
streptococcal antigens
Jae Yong Chang, Ju Hee Lee, Wen Hao Wu, Kwang Hoon Lee, Dongsik Bang
3) Erythema nodosum: Clinicopathologic correlation
Sang Won Lee, En Hyung Kim, Hee Young Kang, You Chan Kim, Eun-So Lee
4. Clinical symptoms and treatment
1) A case of Behçet’s disease with right ventricular thrombus and pulmonary aneurysm 
You-Hyun Lee, Ji-Su Lee
2) Two child cases of Behçet’s disease presenting with colon ulcer as initial presentation
Ji-Tae Kim, Kyong-Min Choi, Dong Soo Kim
3) Clinical characteristics of patients with cardiac involvement in Behçet’s disease
Kyoung-Min Park, Jae-Kwan Song, Duk-Hyun Kang, Bong-Ryong Choi, Jae-Joong Kim,              
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7th Academic Meeting of the Korean Society for Behçet’s Disease
December 1, 2006
East Building 4th floor small auditorium & exhibit hall, 
Asan Medical Center, Seoul, Korea
Invited speakers
Michael Schirmer
Associate Professor of Medicine, Innsbruck Medical University
Head, Department of Internal Medicine, General Hospital of the 
Elisabethinen Klagenfurt and Center of Rheumatic Diseases,             
Klagenfurt, Austria
Fumio Kaneko
Director and Chairman, Institute of Dermato-Immunology and Allergy, 
Southern TOHOKU Research Institute of Neuroscience, Fukushima, Japan
Special lecture
Premature immunosenscent CD28 T-cells in patients with chronic inflammatory rheumatic diseases
Michael Schirmer
Free Communication
1. Government policy and support for rare diseases (Behçet’s disease)
1)  Behçet’s disease in Japan: The research committee for Behçet’s disease organized by the Japanese 
ministry of labor, health and welfare, 1972-2006
Fumio Kaneko
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2.  Role of rebamipide in the treatment of recurrent aphthous ulcer in Behçet’s disease: Result of 
multicenter study in Korea 
Eun-So Lee






8th Academic Meeting of the Korean Society for Behçet’s Disease
November 30, 2007
Research Building I Auditorium, Asan Medical Center, Seoul, Korea
Invited speaker
Yoshiaki Ishigatsubo
Professor and Chairman, The First Department of Internal Medicine, 
Yokohama City University School of Medicine, Yokohama, Japan
Special lecture
Role of Heme oxygease-1(HO-1) in Behçet’s disease
Yoshiaki Ishigatsubo
Free communication
1. Epidemiology and clinical symptoms
1) Clinical manifestations associated with gender in Korean Behçet’s disease patients 
Hee-Jung Ryu, Hyo-Jin Choi, Han-Ju Baek
2) Evaluation of the articular involvement of Behçet’s disease via Yc-99m-HDP bone scintigraphy 
Eun Chun Han, Sang Ho Oh, Kyu-yeop Lee, Ju Hee Lee, Dongsik Bang
3)  Clinical manifestations associated with high titer of anti-streptolysin O in Behçet’s disease:              
Clinical implication of the role of Streptococci
Sang Ho Oh, Kyu-yeop Lee, Ju Hee Lee, Dongsik Bang
4)  Cardiac Behçet’s disease presenting as aortic valvulitis/aortitis or right heart inflammatory mass:          
A clinicopathologic study of 12 cases
Sohyung Park, Ilseon Hwang, Mi-Jeong Kim, Seong-Su Nah, Bin Yoo, Jae-Kwan Song, Inchul Lee
2. Genetics and research





Eun Bong Lee, Jeong Yeon Kim, Jinying Zhao, Myong Hee Park
2)  Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behçet’s disease
Jeong-Eun Do, Su-Yeon Kwon, Sun Park, Eun-So Lee
3) Th17 associated cytokine profile in cutaneous lesion of Behçet’s disease
Kyu-yeop Lee, Sang Ho Oh, Dongsik Bang
4)  Rebamipide affects the efficiency of colchicine for the herpes simplex virus-induced inflammation in 
a Behçet’s disease mouse model
Seonghyang Sohn, Dongsik Bang, Bunsoon Choi, Hyuk Jae Kwon, Eun-So Lee, Sungnack Lee
3. Clinical manifestations and treatments
1) Three cases of pyoderma gangrenosum associated with Behçet’s disease
Jin-Young Jung, Eun Chun Han, Sang Ho Oh, Ju Hee Lee, Dongsik Bang
2) Effect of sulfasalazine for the treatment of refractory oral ulcers in Behçet’s disease patients
Mi-Ra Lee, Hyo-Jin Choi, Han-Ju Baek
3)  Behçet’s disease complicated with bone marrow failure in Korea: Clinical characteristics and the 
association of intestinal ulceration and trisomy 8
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9th Academic Meeting of the Korean Society for Behçet’s Disease
November 14, 2008
Cancer Research Institute 2nd floor Lee Kun-Hee Hall, 
Seoul National University Hospital, Seoul, Korea
Invited speaker
Dorian O. Haskard 
Director, The Eric Bywaters Centre, National Heart and Lung Institute,
Cardiovascular Medicine Unit, London, United Kingdom
Special lecture
Imaging endothelial cell activation and adhesion









1.  Report on the 13th International Conference on 
Behçet’s Disease
Sang Ho Oh 
2.  Development of clinical research network for 
Behçet’s disease 
Eun-So Lee
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10th Academic Meeting of the Korean Society for Behçet’s Disease
November 13, 2009
Children’s Hospital Lecture room II, Seoul National University Hospital, Seoul, Korea
Invited speaker
Seong-Jin Kim
Director, Lee Gil Ya Cancer and Diabetes Research Institute, and Lee Gil Ya 
Distinguished Professor of Medicine, Gachon University of Medicine and 
Science, Incheon, Korea
Professor, Ireland Cancer Center, Case Western Reserve University School 
of Medicine, Cleveland, OH, USA
Korea-Japan joint symposium part I: Ocular Behçet’s disease
1. Recent cases of ocular Behçet’s disease in Japan
Toshikatsu Kaburaki
2. Clinical features of ocular Behçet’s disease in Korea
Hyeong Gon Yu
Korea-Japan joint symposium part II: Infection and Behçet’s disease
1. The role of Streptococcus antigen in Behçet’s disease
Koichiro Nakamura
2.  CD4+ CD25+ regulatory T cells alleviated the herpes simplex virus induced inflammation in Behçet’s 
disease-like mouse model
Seonghyang Sohn
Korea-Japan joint symposium part III: Intestinal Behçet’s disease






2. Development of diagnostic criteria for intestinal Behçet’s disease
Jae Hee Cheon, Won Ho Kim
Korea-Japan joint symposium part IV: Genes in Behçet’s disease
1. Genetics of Behçet’s disease in a Korean population
Eun Bong Lee
2. Inflammasome-related genes in Behçet’s disease
Yoshiaki Ishigatsubo
Special lecture
Crosstalk between pro-inflammatory and TGF-beta anti-inflammatory pathways
Seong-Jin Kim
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11th Academic Meeting of the Korean Society for Behçet’s Disease
October 29, 2010
Cancer Research Institute 2nd floor Lee Kun-Hee Hall, 
Seoul National University Hospital, Seoul, Korea
Invited speakers
Nobuhisa Mizuki
Professor and Chairman, Department of Ophthalmology, Yokohama City 
University Graduate School of Medicine, Yokohama, Japan
Graham Wallace
Senior Lecturer, Academic Unit of Ophthalmology, Division of Immunity 
and Infection, University of Birmingham, Edgbaston, Birmingham, United 
Kingdom
Invited lectures
1. Genome-wide association studies on Behçet’s disease in Japan 
Nobuhisa Mizuki
2. A darwinian view of Behçet’s disease
Graham Wallace
Educational lectures
1. Stem cell approach to intractable diseases
Seung-Yup Ku
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Other reports and free communication
1. Report on the 14th International Conference on Behçet’s Disease 
Sung Bin Cho
2. Free communication
1) HnRNP-A2/B1 as a target antigen of anti-endothelial cell IgA antibody in Behçet’s disease
Sung Bin Cho, Keun Jae Ahn, Suhyun Cho, Do Hee Kim, Shin-Wook Kang, Ju Hee Lee,                
Yong-Beom Park, Kwang Hoon Lee, Dongsik Bang
2) Beneficial effect of galectin-9 on Behçet’s disease-like mouse model
Ju A Shim, Sun Park, Eun-So Lee, Toshiro Niki, Mitsuomi Hirashima, Seonghyang Sohn
3)  Expression of pro-inflammaoty protein S100A12 (EN-RAGE) in Behçet’s disease and its association 
with disease activity
Eun Chun Han, Sung Bin Cho, Keun Jae Ahn, Sang Ho Oh, Jihyun Kim, Dong Soo Kim,              
Kwang Hoon Lee, Dongsik Bang
4) Chemokine expression of intraocular lymphocytes in patients with Behçet uveitis





12th Academic Meeting of the Korean Society for Behçet’s Disease
November 18, 2011
Cancer Research Institute 2nd floor Lee Kun-Hee Hall, 
Seoul National University Hospital, Seoul, Korea
Invited speakers
Ahmet Gül
Professor of Medicine, Department of Internal Medicine, Division of 
Rheumatology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
Educational lectures 
Treatment for oral manifestations of Behçet’s disease
1)  Recurrent Aphthous Stomatitis: Manifestations and treatments of patients in department of oral 
medicine
Hong-Seop Kho
2) Manifestation and treatment of otorhinolaryngologic patients
Tack-Kyun Kwon
3) Comparison of the clinical features of recurrent aphthous stomatitis and Behçet’s disease 
Sung Bin Cho
4) Management of severe recurrent aphthous ulcers in patients with Behçet’s disease
Suhyun Cho
Special lecture
Behçet’s disease from bench to bedside: what to expect from basic sciences
Ahmet Gül
Oral presentations
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2. Maturation profiles of peripheral blood dendritic cells in patients with endogenous uveitis 
Tae-Wan Kim
3. Effect of sodium lauryl sulfate on recurrent aphthous stomatitis 
Young-Joo Shim
4. Renal manifestations in 2007 Korean patients with Behçet’s disease
Hong Sun Jang
5. Solid Cancer in Behçet’s Disease: a report of 11 cases in a series of 506 patients
So Young Na






13th Academic Meeting of the Korean Society for Behçet’s Disease
November 30, 2012
Cancer Research Institute 2nd floor Lee Kun-Hee Hall, 
Seoul National University Hospital, Seoul, Korea
Japan-Korea joint symposium I
1. Recalcitrant manifestations in Behçet’s disease
Shunsei Hirohata
2. Vascular Behçet’s disease and case presentation
Chang-Keun Lee
3. Outcome predictors for medical treatment in intestinal Behçet’s disease
Jae Hee Cheon
Japan-Korea joint symposium II
1. Progress in the treatment of ocular inflammation in Behçet’s disease
Manabu Mochizuki
2. Case presentations of Korean Behçet’s uveitis and panel discussion
Ji-Eun Lee, Jae-Ryung Oh
Other reports and free communication
1. Report on the 15th International Conference on Behçet’s Disease
Do Young Kim
2. Free communication
1) Evolution of clinical manifestations in Behçet’s disease: The past and the present
Min Ju Choi, Suhyun Cho, Zhenlong Zheng, Do Young Kim, Sung Bin Cho, Dongsik Bang
2) Characteristics of optical coherence tomography in patients with Behçet’s uveitis
Dong Min Cha, Hyeong Gon Yu
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4) Immunopathogenic characterization of cutaneous inflammation in Behçet’s disease
Suhyun Cho, Jihyun Kim, Sung Bin Cho, Zhenlong Zheng, Min Ju Choi, Do Young Kim,               
Dongsik Bang
5)  The role of classical or alternative activation of macrophage in the immunopathogenesis of Behçet’s 
disease in animal model
A.K.M. Mostafa Anower, Ju A Shim, Bunsoon Choi, Hyuk Jae Kwon, Seonghyang Sohn
6) CD11a, CD11c and CD18 gene polymorphisms and susceptibility to Behçet’s disease in Koreans





14th Academic Meeting of the Korean Society for Behçet’sDisease (Tentative Plan)
November 22, 2013
NEWILHAN Memorial Hall of Avison Biomedical Research Center, 
Yonsei University, Seoul, Korea
Invited speaker
Isabelle Koné-Paut
Department of Pediatrics and Pediatric Rheumatology, 
University of Paris SUD, Bicêtre Hospital, Paris, France
Rheumatology Session
1) Rheumatic diseases in children 
Youn-Soo Hahn (Department of Pediatrics, Chungbuk National University, Korea)
2) Neuro-Behçet’s disease in children 
Ki Hwan Kim (Department of Pediatrics, Yonsei University, Korea)
3) Clinical challenges in the diagnosis of Behçet’s disease in children 
Isabelle Koné-Paut (Department of Paediatrics and Paediatric Rheumatology, Bicêtre Hospital, 
National Reference Centre for Autoinflammatory Diseases, France)
Ophthalmology Session
1) Inhibition of IkB kinase ameliorates acute uveitis in rats 
Nobuyoshi Kitaichi (Department of Ophthalmology, Hokkaido University, Japan)
2) Novel scoring system of ocular lesions in Behçet’s disease 
Kenichi Namba (Department of Ophthalmology, Hokkaido University, Japan)
3) Imaging studies in Behçet’s uveitis 
Sung Chul Lee (Department of Ophthalmology, Yonsei University, Korea)
4) Disease mechanisms and treatment of Behçet’s disease 





4) Research Funds from the Government of Republic of Korea
-  Cooperation studies on Behçet’s disease by the members of the Korean Society for Behçet’s disease supported by 
the Korean government
1.  Study project title: A study of formation of diagnostic criteria suitable for Korean and 
pathophysiology on Behçet’s disease
The Korean Ministry of Health and Welfare Grant Number: HMP-97-M-2-0041
Duration of Study: May 1st, 1997 - April 30th, 2000
PI: Dongsik Bang
Subtitles
1)  Dongsik Bang, Professor, Department of Dermatology, Yonsei University College of Medicine: 
Characterization of epidemiological and clinical features of Behçet’s disease in Korea
2)  Kwang Hoon Lee, Professor, Department of Dermatology, Yonsei University College of Medicine: Role 
of endothelial cells in Behçet’s disease
3)  Soo Kon Lee, Professor, Department of Rheumatology, Yonsei University College of Medicine: Study 
on the characteristics of immunoglobulin genes in Behçet’s disease
4)  Jaehoon Roh, Professor, Department of Preventive Medicine, Yonsei University College of Medicine: 
Study on the effects of environmental factors in the pathophysiology of Behçet’s disease
5)  Seonghyang Sohn, Professor, Laboratory of Cell Biology, Ajou University Institute for Medical Sciences: 
Development of Behçet’s disease animal model and investigation on the pathogenesis of Behçet’s 
disease using this model
2.  Study project title: Study on the mutual (complementary) development plan of western 
medicine and oriental medicine 





Duration of Study: July 1st, 1999 - October 31st, 2000
PI: Jong Ku Park 
Subtitle
1)  Dongsik Bang, Professor, Department of Dermatology, Yonsei University College of Medicine: Study 
on the therapeutic effect of combined treatment of western and herbal medicines in Behçet’s disease 
animal model
3.  Study project title: Development of a clinical decision making algorithm and a patient 
registration system in Korean Behçet’s disease
Research Coordination Center for Rare Diseases Grant Number: A080588-16 certified by The Korean
Ministry of Health and Welfare
Duration of Study: August 1st, 2008 – March 31st, 2012
PI: Eun-So Lee, 
Other investigators: most of members of the Korean Society for Behçet’s Disease
4.  Study project title: Establishment and management of clinical study network for Behçet’s 
disease
Korea Centers for Disease Control and Prevention, Grant Number: 2012-E63008-00
Duration of Study: June 1st, 2012 – December 31st, 2012
PI: Eun-So Lee, 








 2004.11.26(Article 9, 10, 14)
 2008.11.14(Article 5, 6, 7)
Chapter 1. General Rules
Article 1(Name).  The society shall be called ‘The Korean Society for Behçet’s Disease’, herein after referred 
to as KSBD.
Article 2(Composition). KSBD consists of those involved in research relevant to Behçet’s Disease.
Article 3(purpose). KSBD is established to promote member relationship and exchange of information 
through various academic activities with regard to Behçet’s Disease.
Article 4(Affairs). KSBD is to execute the following affairs to achieve the above-mentioned purposes:
 - Holding general assemblies and academic conferences;
 - Publishing abstracts, academic journals and newsletters;
 -  Carrying out affairs pertaining to extensive areas including research and 
education on Behçet’s Disease;
 -  Establishing exchanges and affiliation with related academic groups at home and 
abroad;
 - Executing other affairs necessary to achieve KSBD’s purposes.
Chapter 2. Membership
Article 5(Qualification). Members of KSBD are scholars conducting research and treatments on Behçet’s 
Disease in basic and clinical fields and accept the society’s purposes and thus 
submit the application form and annual subscriptions to obtain the membership.
Article 6(Classification). Members of KSBD are classified as follows.
 -  Full membership: Members who meet the requirements stated in Article 5, go 





committee shall win full membership. 
 -  Corresponding membership: Members overseas engaging in the fields related to 
Behçet’s Disease who endorse the club’s objectives will win overseas membership.
 -  Honorary membership: Members with remarkable research achievements and 
those who have given lectures at academic conferences on invitation or who have 
made significant contributions to the development of KSBD will win honorary 
membership. 
 -  Group membership: Groups or research institutions endorsing the club’s 
objectives will win group membership.
Article 7(Obligations). KSBD’s members are to comply with the club bylaws, regulations and resolutions. 
Full and group members should pay annual subscriptions and other fees to cover 
the operating costs of the society.
Article 8(Rights). Full members are to be given rights to vote, to be elected and to resolve particular issues.
Chapter 3. Organization
Article 9. KSBD should operate the following organs: general affairs, academic, accounting, and public 
relations departments. 
Chapter 4. Board Members/ Executives
Article 10(Qualification). KSBD’s board membership consists of a chairman, an auditor, and heads of four 
departments (general affairs, academic, accounting, public relations).
Article 11(Appointment). The chairman and the auditor shall be elected at a general assembly and the vice 
chairman shall be nominated by the chairman.
Article 12(Term). A board member’s term is two years and can be extended to a second term. In case of 
a vacant post by accidents, the replacement shall serve the remaining term of the 
predecessor.
Article 13(Duties). The chairman, representing KSBD, is to take full charge of administrative affairs and 
serve as a general assembly chairman. The auditor is to review important issues 





Article 14. KSBD can appoint an honorary chairman by general assembly resolutions by those chairmen 
who have made considerable contributions to the club. 
Chapter 5. Assembly
Article 15(Classification). KSBD holds a general assembly.
Article 16(General assembly). A regular annual general assembly is convened by the chairman. But, the 
chairman should summon a temporary general assembly when there are demands 
by more than a fifth of the members. 
 -  A general assembly is valid/ established with the presence of full members and 
resolutions are passed by a majority vote of those present.







Article 17(Finances/Source of revenue). KSBD is financed by membership fees, donations, and other 
sources of income.
Article 18(Fiscal year). KSBD’s fiscal year runs from the day of a regular annual general assembly through 
the day before the following year’s general assembly.
Article 19(Term). Account settlement of the club is to be reported at the next regular general assembly.
Chapter 7. Supplementary provisions/ Additional rules/ Subsidiary laws
Article 20. Detailed rules not stated in the concerned bylaws shall be subject to general practice.





6) Society Emblem 
The first emblem of the Korean Society for Behçet’s Disease was made by Professor Dongsik Bang in 2000. 
The symbol represented two major organs, the skin and the eye which Behçet’s disease commonly involved. 
The pupil of the eye embodied the yin-yang symbol, or taegeuk symbol in the national flag of Republic of 
Korea. The two letters ‘B’ and ‘D’ was appreciations for Behçet’s Disease.
The second emblem was made in 2008 by Woonggi Lee, the second son of Professor Sungnack Lee and 
has been used as the main emblem of the Korean Society for Behçet’s disease ever since.
The 1st Emblem of the Korean Society for Behçet’s 
Disease created in 2000










1st July 11, 1991 Istanbul, Turkey
2nd October 14, 1993 Suwon, Korea
3rd September 4, 1995 Istanbul, Turkey
4th October 10, 1997 Gyeongju, Korea





1st Korea-Turkey Joint Meeting of Behçet’s Disease
July 11, 1991 
Istanbul, Turkey
1. Behçet’s disease in Korea
D. Bang1, S. Lee1, HB Kim2, WP Hong2 
(1Department of Dermatology and 2Department of Otorhinolaryngology, Yonsei University College 
of Medicine, Seoul, Korea) 
2. The importance of standard prick depth in skin pathergy test in Behçet’s disease 
A. Iscimen, S. Serdaroglu, Y. Tuzin 
(Department of Dermatology, Cerrahpasa Faculty of Medicine, Istanbul University)
3. Serum sialic acid levels in patients with Behçet’s disease 
I.T. Tutkun, M. Urgancioglu, N. Gozum 
(Department of Ophthalmology, Istanbul Faculty of Medicine, Istanbul University)  
4. Low dose cyclosporine therapy in Behçet’s disease 
S. Bayraktar, M. Urgancioglu, B. Izgi 
(Department of Ophthalmology, Istanbul Faculty of Medicine, Istanbul University)  
5. Paroxysmal dysarhria-ataxia in a patient with neuro-Behçet’s disease 
G. Akman (Department of Neurology, Istanbul Faculty of Medicine, Istanbul University)
6.  Spontaneous dissection of extracranial vertebral artery with spinal SAH in a patient with Behçet’s 
disease 
S. Bahar, O. Coban, H. Gurvit, G. Akman, A. Gokyigit 
(Department of Neurology, Istanbul Faculty of Medicine, Istanbul University)
7. A new kind of skin lesion in Behçet’s disease- Extragenital ulcerations 
J. Tok, G. Azizlerli, G. Özarmağan, C. Ovul, R. Sarica. S.O. Mustafa 
(Department of Dermatology, Istanbul Faculty of Medicine, Istanbul University)
8. Familial cases in Behçet’s disease 
J. Tok, G. Azizlerli, R.Sarica, C. Ovul, T. Sabanoglu, O. Tulimat, H. Othman 










Professors Won Pyo Hong, Dongsik Bang, and Hong 
Bok Kim at the 1st Korea-Turkey Joint Meeting of 
Behçet’s Disease
Professors Sungnack Lee and Türkan Saylan at the 1st 
Korea-Turkey Joint Meeting of Behçet’s Disease
Professors Dongsik Bang and Türkan Saylan at the 1st 
Korea-Turkey Joint Meeting of Behçet’s Disease
Professors Dongsik Bang and Sungnack Lee and at the 





2nd Turkey-Korea Joint Meeting of Behçet’s Disease
October 14, 1993
Ajou University, College of Medicine, Suwon, Korea
Opening Remarks 
Sungnack Lee (Yonsei University, Korea)
1. Short life story of Dr. Hûlusi Behçet.  
T. Saylan
2. History of Behçet’s disease in Korea. 
S. Lee
3. Clinical studies on pathergy test in Turkey. 
G. Özarmağan
4. Practical drug treatment of Behçet’s disease. 
C. Mat
5. The etiological role of streptococcal antigen in Behçet’s disease. 
F. Kaneko
6. Unusual cases of Behçet’s disease.
D. Bang
 1) Case 1. A case of Behçet’s disease showing pyoderma gangrenosum-like lesion.
 2) Case 2. A case of Behçet’s disease showing an abnormal scrotal mass.
 3) Case 3.  Steroid pulse therapy in a patient with neuro-Behçet’s disease developed during pregnancy.
7. EM-like skin lesions in Behçet’s disease. 
D. Bang
8. Detection of HSV DNA by PCR in saliva of patients with Behçet’s disease. 
E.-S. Lee
9. Detection of HSV DNA in EN-like skin lesions of patients with Behçet’s disease.
E.-S. Lee
Closing Remarks 





Abstract cover of the 2nd Korea-Turkey Joint Meeting 
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3rd Korea-Turkey Joint Meeting of Behçet’s Disease
September 4, 1995
Istanbul University, Merkez Bina Doktora Salonu, Istanbul, Turkey
Opening Remarks
Bülent Berkarda (Istanbul University, Turkey) , Türkan Saylan (Istanbul University, Turkey) ,   
Sungnack Lee (Yonsei University, Korea) , Hasan Yazici (Istanbul University, Turkey)
Session I
Chairpersons; 
Türkan Saylan (Istanbul University, Turkey), Fumio Kaneko (Fukushima University, Japan)
1. Review of Diagnostic Criteria of Behçet’s disease. 
Sungnack Lee, Dongsik Bang, Eun-So Lee
2. Epidemiology and recent immunological research trends of Behçet’s disease in Japan. 
Fumio Kaneko, Hitoshi Akiba, Yasuyuki Kikkawa
3. Streptococcal antigens and role of cytokines in pathogenesis of Behçet’s disease. 
Fumio Kaneko, Hitoshi Akiba, Noritaka Oyama, Yasuyuki Kikkawa
4. Is Behçet’s disease an autoimmune disorder? 
Hasan Yazici
5. Gastrointestinal involvement in Behçet’s syndrome: a controlled study. 
Sebahattin Yurdakul, Nükhet Tüzüner, Ibrahim Yurdakul, Vedat Hamuryudan, Hasan Yazici
6. Wound healing in Behçet’s syndrome. 
Cem Mat, Marina Nazarbaghi, Yalçin Tüzün, Vedat Hamuryudan, Nail Hizli, Sebahattin Yurdakul, 







Hasan Yazici (Istanbul University, Turkey) , Sungnack Lee (Yonsei University, Korea)
1.  Ultrastructural changes of cultured human dermal microvascular endothelial cells (HDMEC) after 
treating with the sera of Behçet’s disease patients. 
Dongsik Bang, Kwang Hoon Lee, Un Sun Choi, Hyun Joo Choi, Eun-So Lee, Sungnack Lee
2.  Herpes simplex virus detection by polymerase chain reaction in intestinal ulcer of patients with Behçet’s disease. 
Eun-So Lee, Sungnack Lee, Dongsik Bang, Seonghyang Sohn, Chanil Park, Kyibeom Lee
3. Behçet’s disease-like symptom induced by herpes simplex virus ICR mice. 
Seonghyang Sohn, Eun-So Lee, Dongsik Bang, Sungnack Lee
4. B cell epitope mapping of 65kDa HSP in Behçet’s disease. 
Direskeneli H, Hasan A, Shinnick T, Mizushima Y, Van der Zee, Fortune F, Stanford MR, Lehner T
5. Expression of MHC-Class II molecules on neutrophils obtained from patient with Behçet’s disease.
Sükran Sahin, Tevfik Akoğlu, Haner Direskeneli, Hasan Yazici
Closing Remarks
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Group Photo of the 3rd Turkey-Korea Joint Meeting of 
Behçet’s Disease
Oral Presentation of Professor Dongsik Bang at the 3rd 
Turkey-Korea Joint Meeting of Behçet’s Disease 
Group Photo of the 3rd Turkey-Korea Joint Meeting of 
Behçet’s Disease






4th Turkey-Korea Joint Meeting of Behçet’s Disease
October 10, 1997
Hilton Hotel, Kyongju, Korea
Opening Remarks
Sungnack Lee (Yonsei University, Korea) , Aysel Gürler (Ankara University, Turkey) ,                                
Jae Bok Jun (Kyungpook National University, Korea)
Session I
Chairpersons; 
Jae Bok Jun (Kyungpook National University, Korea) , Fumio Kaneko (Fukushima University, Japan)
1. Clinical observation of 3,000 patients with Behçet’s disease. 
Aysel Gürler
2. Recurrent aphthous ulcer and Behçet’s disease. 
Dongsik Bang
3. Behçet’s syndrome in children; a report of 72 patients. 
Sebahattin Yurdakul
4. HLA distribution in Korean patients with Behçet’s disease. 
Young Mo Kang
5. Vascular Behçet’s disease. 
Eun-So Lee
6. Gastrointestinal involvement of Behçet’s disease. 
Eun Jung Nam








Sungnack Lee (Yonsei University, Korea), Cem Mat (Istanbul University, Turkey)
1. Clinical features of 6 patients with Behçet’s disease showing ANCA positive. 
Kyeong Han Yoon
2. Level of serum elastase-α1-antitrypsin in patients with Behçet’s disease. 
Jae Bok Jun
3. Study on the circulating Ab in the sera of Behçet’s disease using HDMEC. 
Kwang Hoon Lee
4. Androgen receptor density in scrotal skin of Behçet’s syndrome. 
Cem Mat
5. Is cromolyn gel 4% effective in the treatment of genital ulcers of Behçet’s syndrome?
Cem Mat
6. Thalidomide in Behçet’s syndrome: a randomized and placebo controlled trial. 
Vedat Hamuryudan
7. Minocycline effects in the clinical symptoms in Behçet’s disease affected by streptococcal infection.
Fumio Kaneko
Closing Remarks  





Abstract cover of the 4th Korea-Turkey Joint Meeting 
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5th Korea-Turkey Joint Meeting of Behçet’s Disease
September 6, 1999
Ankara University, Ibni Sina Hospital, Ankara, Turkey
Opening Remarks
Günal Akbay (Ankara University, Turkey) , Nusret Aras (Ankara University, Turkey) ,                           
Sungnack Lee (Yonsei University, Korea), Aysel Gürler (Ankara University, Turkey)
Session I
Chairpersons; 
Sungnack Lee (Yonsei University, Korea) , Türkan Saylan (Istanbul University, Turkey)
1. Behçet’s disease or Behçet’s syndrome. 
Lee S
2. Dermatologic manifestations of Behçet’s disease. 
Bang D, Lee E-S, Lee S
3. Clinical manifestations of late-onset Behçet’s disease.
Lee S, Lee E-S, Bang D, Jun JB
4. Behçet’s disease and pregnancy: A retrospective analysis and review of the literature. 
Uzun S, Memişoğlu HR
5. Behçet’s disease prevalence study over 10-year age in park health care center. 
ĺdil A, Gürler A, Boyvat A, Çalişkan D, Özdemir Ö, Işik A, Tunçbilek A, Koçyiğit P, Çalikoğlu E
6. The prevalence of lower intestinal involvement of Behçet’s disease. 
Kang YM, Kim GW, Bae HI, Kim NS, Jun JB
7. Neuro Behçet’s disease. 
Selçuki D, Aydin N, Togay C
8. Subclinical cerebral involvement in Behçet’s disease: A SPECT study. 





9. Helicobacter pylori and Behçet’s disease. 
Avci O, Ellidokuz E, Şimşek ĺ, Büyükgebiz B, Güneş AT
Session II
Chairpersons; 
Hasan Yazici (Istanbul University, Turkey), Aysel Gürler (Ankara University, Turkey)
1.  Expression changes of endothelial cell adhesion molecules may be influenced by cytokines produced by 
IgM anti-endothelial cell antibodies in sera of Behçet’s disease patients. 
Lee KH, Cho HJ, Lee S, Bang D
2.  Th1 and Th2 cytokines regulate the development and improvement of Behçet’s disease induced by 
herpes simplex virus inoculation in mouse model. 
Sohn S, Lee SI, Lee E-S, Kwon HJ, Bang D, Lee S
3. Changes of nitric oxide levels in Behçet’s disease. 
Sancak B, Önder M, Öztaş MO, Bukan N, Gürer MA
4.  The response to the intradermal injection of monosodium urate in Behçet’s syndrome (BS) and its 
comparison to the pathergy test. 
Fresko ĺ, Özsoy Y, Mat C, Melikoğlu M, Tunç R, Yurdakul S, Hamuryudan V, Yazici H
5. Myeloperoxidase activity of neutrophils exposed to monosodium urate in Behçet’s disease. 
Melikoğlu M, Özbakir F, Hekim C, Hekim N, Fresko ĺ, Tunç R, Yazici H
6. Factor analysis in Behçet’s syndrome. 
Tunç R, Keyman M, Melikoğlu M, Fresko ĺ, Hamuryudan V, Yurdakul S, Mat C, Özyazgan Y, Yazici H
7. Emotional characteristics of Behçet patients’ relatives. A comparative study. 
Okyayuz üH
8. Long term effects of interferon alpha-2a treatment in Behçet’s disease. 
Boyvat A, Solak C, Gürler A
9. A good therapy modality for pulmonary arterial aneurysm in Behçet’s disease. 
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1st July 20, 2007 Yokohama, Japan
2nd November 13, 2009 Seoul, Korea
3rd December 16, 2011 Yokohama, Japan
4th November 30, 2012 Seoul, Korea





1st Japan-Korea Joint Meeting on Behçet’s Disease
July 2, 2007
Yokohama Landmark Tower 13F, Extension Center, Yokohama City University, 
Yokohama, Japan
Opening Remarks 
Ishigatsubo Y. (Yokohama City University Graduate School of Medicine, Japan)
Session 1
Introduction; 
Brief history of academic society in each country, future joint research fields etc.
Chairperson; 
Ishigatsubo Y. (Yokohama City University Graduate School of Medicine, Japan)
1. Clinical features of Behçet’s disease in Japan 
Ohno S. (Hokkaido University Graduate School of Medicine, Japan)
2. Behçet’s disease in Korea 
Bang D. (Yonsei University College of Medicine, Korea)
Session 2
Chairpersons; 
Inoko H. (Tokai University School of Medicine, Japan)                                                                       
Lee S. (Gachon University of Medicine and Science, Korea)
1. Treatment of Behçet’s disease with infliximab
Ohno S. (Hokkaido University Graduate School of Medicine, Japan)
2. The long-term follow-up of Behçet’s uveitis in Korean population 
Yu HG. (Seoul National University College of Medicine, Korea)





Meguro A. (Yokohama City University Graduate School of Medicine, Japan)
4. Symptom-associated chemokine genes in a Behçet’s disease mouse model 
Sohn S. (Ajou University School of Medicine, Korea)
5. Roles of cytotoxic lymphocytes in pathogenesis of Behçet’s disease 
Kuwana M. (Keio University, Japan)
Session 3
Chairpersons; 
Oguma K. (Okayama University Graduate School of Medicine, Japan)
Bang D. (Yonsei University College of Medicine, Korea)
1.  Involvement of TLR4 dependent down-regulation of heme oxygenase-1 in leukocyte activation of 
Behçet’s disease 
Takeno M. (Yokohama City University Graduate School of Medicine, Japan)
2. Effects of vitamin D on expression of Toll-like receptors in Behçet’s disease 
Lee E-S. (Ajou University School of Medicine, Korea)
3. Immune and inflammatory responses in Behçet’s disease 
Suzuki N. (St. Marianna University School of Medicine, Japan)
4.  Multicenter study on the therapeutic efficacy of rebamipide (MucostaTM) in the treatment of recurrent 
aphthous ulcers in patients with Behçet’s disease 
Lee E-S. (Ajou University School of Medicine, Korea)
5. Hypersensitivity of T cells in Behçet’s disease to a variety of bacterial antigens 
Hirohata S. (Kitazato University School of Medicine, Japan)
6.  Serum galectin-3 and galectin-4 binding protein levels in Behçet’s disease and their association with 
disease activity 
Song YW. (Seoul National University College of Medicine, Korea)
Session 4
Chairperson; 





1. Behçet’s disease: From infection to autoimmunity 
Direskeneli H. (Marmara University of Medicine and Science, Turkey)
Closing Remarks
Lee S. (Gachon University of Medicine and Science, Korea)
Abstract cover of the 1st Korea and Japan 
Joint Meeting on Behçet’s Disease
Professors Seonghyang Sohn, Sungnack Lee, Eun-So Lee, Dongsik Bang, and Hyeong 





2nd Korea-Japan Joint Meeting on Behçet’s Disease
November 13, 2009
Children’s Hospital Lecture room II, Seoul National University Hospital, 
Seoul, Korea
Session 1 Ocular Behçet’s Disease
Chairperson; 
Sung Chul Lee (Yonsei University College of Medicine, Korea)
1. Recent cases of ocular Behçet’s disease in Japan 
Toshikatsu Kaburaki (The University of Tokyo, Japan)
2. Clinical features of ocular Behçet’s disease in Korea 
Hyeong Gon Yu (Seoul National University College of Medicine, Korea)
Session 2 Infection and Behçet’s Disease
Chairperson; 
Fumio Kaneko (Southern TOHOKU Research Institute for Neuroscience, Japan)
1. The role of Streptococcus antigen in Behçet’s disease 
Koichiro Nakamura (Saitama Medical University, Japan) ,                                                       
Fumio Kaneko (Southern TOHOKU Research Institute for Neuroscience, Japan)
2.  CD4+ CD25+ regulatory T cells alleviated the herpes simplex virus induced inflammatory in Behçet’s 
disease-like mouse model 
Seonghyang Sohn (Ajou University School of Medicine, Korea)
Session 3 Intestinal Behçet’s Disease
Chairperson; 





1. Management of intestinal Behçet’s Disease 
Mitsuhiro Takeno (Yokohama City University Graduate School of Medicine, Japan)
2. Development of diagnostic criteria for intestinal Behçet’s disease 
Jae Hee Cheon, Won Ho Kim (Yonsei University College of Medicine, Korea)
Session 4 Genes in Behçet’s Disease
Chairperson; 
Yeong Wook Song (Seoul National University College of Medicine, Korea)
1. Genetics of Behçet’s disease in a Korean population
Eun Bong Lee (Seoul National University College of Medicine, Korea)
2. Inflammasome-related genes in Behçet’s disease 
Yoshiaki Ishigatsubo (Yokohama City University Graduate School of Medicine, Japan)
Special Lecture
Chairperson; 
Yong Il Kim (Gachon University of Medicine and Science, Korea)
Crosstalk between pro-inflammatory and TGF-beta anti-inflammatory pathways 





3rd Japan-Korea Joint Meeting on Behçet’s Disease
December 16, 2011
Yokohama City University Graduate School of Medicine, Yokohama, Japan
Opening Remarks
Yoshiaki Ishigatsubo (Yokohama City University Graduate School of Medicine, Japan)
Session 1
Chairpersons; 
Sungnack Lee (Gachon University of Medicine and Science, Korea)
Shigeaki Ohno (Hokkaido University Graduate School of Medicine, Japan)
1.  Matrix metalloproteinase (MMP)-2, MMP-9, MMP-12, and tissue inhibitor of metalloproteinase 2 
gene polymorphisms and cutaneous expressions in patients with Behçet’s disease
Kyung Sook Park1, Yo Min1, Su Rim Park1, En Hyung Kim2,                                                                 
Dong Jun Lee3, Dongsik Bang4, Eun-So Lee3                                                                                          
 (1Department of Biology, Sungshin Women’s University, Seoul, Korea; 2Department of Dermatology, 
Kwandong University College of Medicine, Goyang, Korea; 3Department of Dermatology, Ajou 
University School of Medicine, Suwon, Korea; 4Department of Dermatology, Yonsei University 
College of Medicine, Seoul, Korea)
2. Mechanism of the recruitment of Th17 in the pathogenic process of Behçet’s disease
Hidetaka Yasuoka, Tsutomu Takeuchi, Masataka Kuwana 
(Keio University School of Medicine, Tokyo, Japan)
3.  Identification of hnRNP-A2/B1 as a target antigen of anti-endothelial cell IgA antibody in Behçet’s 
disease
Sung Bin Cho
(Department of Dermatology and Cutaneous Biology Research Institute, Yonsei University College 







Dongsik Bang (Yonsei University College of Medicine, Korea)
Fumio Kaneko (Southern TOHOKU Research Institute for Neuroscience, Japan)
1. Excessive CD4+ T cells co-expressing IL-17 and IFN γ in patients with Behçet’s disease.
Nobura Suzuki1, Jun Shimizu1, Naruyoshi Fujiwara1, Fumio Kaneko2, Sakae Kaneko3 
(1Department of Immunology and Medicine, St. Marianna University School of Medicine, 
Kawasaki, Japan; 2Department of Dermatology, Fukushima Medical University, Fukushima, Japan; 
3Department of Dermatology, Shimane University Faculty of Medicine, Izumo, Japan)
2. Candidate gene analysis in Behçet’s disease. 
Hyeong Gon Yu 
(Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea)
3. Effects of infliximab therapy in Behçet’s disease. 
Shigeaki Ohno1, Kenichi Namba2, Nobuyoshi Kitachi1, Nobuhisa Mizuki3                             
(1Department of Ocular Inflammation and Immunology, Hokkaido University Graduate School of 
Medicine, Sapporo, Japan; 2Department of Ophthalmology, Hokkaido University Graduate School 
of Medicine, Sapporo, Japan; 3Department of Ophthalmology, Yokohama City University Graduate 
School of Medicine, Yokohama, Japan)
Closing Remarks 
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4th Korea-Japan Joint Meeting on Behçet’s Disease
November 30, 2012
Cancer Research Institute 2nd floor Lee Kun-Hee Hall, 
Seoul National University Hospital, Seoul, Korea
Session 1
Chairperson; 
Eun Mi Koh (Department of Internal Medicine, Sungkyunkwan University School of Medicine, Korea)
1. Recalcitrant manifestations in Behçet’s disease
Shunsei Hirohata 
(Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Japan)
2. Vascular Behçet’s disease and case presentation
Chang-Keun Lee 
(Division of Rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Korea)
3. Outcome predictors for medical treatment in intestinal Behçet’s disease
Jae Hee Cheon (Department of Internal Medicine, Yonsei University College of Medicine, Korea)
Session 2
Chairperson; 
Sung Chul Lee (Department of Ophthalmology, Yonsei University College of Medicine, Korea)
1. Progress in the treatment of ocular inflammation in Behçet’s disease
Manabu Mochizuki 
(Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, Japan)
2. Uveitis case presentation of Behçet’s disease in Korea and discussion
Ji Eun Lee (Department of Ophthalmology, Pusan National University School of Medicine, Korea) , 







Bin Yoo (Department of Internal Medicine, University of Ulsan College of Medicine, Korea)
1. Report on the 15th International Conference on Behçet’s Disease
Do Young Kim (Department of Dermatology, Yonsei University College of Medicine, Korea)
2. Free communication
1) Evolution of clinical manifestations in Behçet’s disease: The past and the present
Min Ju Choi, Suhyun Cho, Zhenlong Zheng, Do Young Kim, Sung Bin Cho, Dongsik Bang
2) Characteristics of optical coherence tomography in patients with Behçet uveitis
Dong Min Cha, Hyeong Gon Yu
3) Neuro-Behçet’s disease; clinical and demographic characteristics in Korea
Da-Lim Yoon, You Jae Kim, Bon San Koo, Min Wook So, Chang-Keun Lee, Bin Yoo
4) Iuumnopathogenic characterization of cutaneous inflammation in Behçet’s disease
Suhyun Cho, Jihyun Kim, Sung Bin Cho, Zhenlong Zheng, Min Ju Choi, Do Young Kim, 
Dongsik Bang
5)  The role of classical or alternative activation of macrophage in the immunopathogenesis of Behçet’s 
disease in animal model
A.K.M. Mostafa Anower, Ju A Shim, Bunsoon Choi, Hyuk Jae Kwon, Seonghyang Sohn
6) CD11a, CD11c and CD18 gene polymorphisms and susceptibility to Behçet’s disease in Koreans





East Asian Forum for Behçet’s Disease,                   




Chairpersons; Dongsik Bang (Yonsei University, Korea) , 
 Fumio Kaneko (Fukushima Medical University, Japan) , 
 Jianzhong Zhang (Peking University, China)
1. Introduction of Behçet’s Disease Symposium.
Dongsik Bang (Yonsei University College of Medicine, Korea)
2. Epidemiology in China “Behçet’s disease: clinical characteristics and therapeutic strategy”.
Sheng-Ming Dai (Second Military Medical University, China)
3.  Diagnostic approach “The role of heat shock protein derived from Streptococcus sanguinis in Behçet’s diseases”.
Koichiro Nakamura (Saitama Medical University, Japan)
4. Immunogenetic aspects.
Eun-So Lee (Ajou University School of Medicine, Korea)
5.  Pathological aspects “Distinct immunopathologic reactions in the mucocutaneous lesions of Behçet’s disease”.
Osamu Yamasaki (Okayama University Graduate School of Medicine, Japan)





Seonghyang Sohn (Ajou University Institute for Medical Sciences, Korea)
Closing Remarks
Fumio Kaneko (Fukushima Medical University School of Medicine, Japan)
Abstract cover of the 2nd Eastern Asia 
Dermatology Congress






BehÇet’s Disease since 1985 (4~15th)
At A Glance
ICBD Date Place
4th 5-6 September, 1985 London, England
5th 14-15 September, 1989 Rochester, Minnesota, United States
6th 30 June-1 July, 1993 Paris, France
7th 10-11 October, 1996 Tunis, Tunisia
8th 7-9 October, 1998 Reggio Emilia, Italy
9th 27-29 May, 2000 Seoul, Korea
10th 27-29 June, 2002 Berlin, Germany
11th 27-31 October, 2004 Antalya, Turkey
12th 20-23 September, 2006 Lisbon, Portugal
13th 24-27 May, 2008 Pörtschach/Klagenfurt, Austria
14th 8-10 July, 2010 London, United Kingdom





4th International Conference on Behçet’s Disease
September 5-6, 1985
Royal College of Physicians Royal College of Physicians, London, England
Local Organizing Committee
Chairman           Thomas Lehner
Vice-Chairman       Collin G. Barnes
Presentations by KSBD members 
1. Immunological aspects of the four types of Behçet’s syndrome.
S. Lee1, D. H. Kim1, D. Bang1, K. H. Lee1, I. W. Nam1, K. Park2 
(1Department of Dermatology and 2Immunology Laboratory, Yonsei University College of Medicine, 
Seoul, Korea)
2. DCNB responsiveness in patients with Behçet’s syndrome.
D. Bang, S. Lee, D. H. Kim, I. W. Nam. 
(Department of Dermatology, Yonsei University 
College of Medicine, Seoul, Korea)
3. Clinical observations of Behçet’s disease.
C. Hong (Department of Ophthalmology, School 
of Medicine, Hanyang University, Seoul, Korea)
4. Clinical aspects of Behçet’s syndrome in Korea.
S. Lee1, D. H. Kim1, D. Bang1, K. H. Lee1, H. J. 
Kim1, H. B. Kim2, W. P. Hong3 
(1Department of Dermatology, 2Department of 
Ophthalmology, and  3ENT Department, Behçet’s 
Syndrome  Specialty Clinic, Yonsei University 
College of Medicine, Seoul, Korea)
Book cover of the Proceedings of the 4th 





5th International Conference on Behçet’s Disease
September 14-15, 1989
Mayo Clinic Mayo Clinic, Rochester, Minnesota, United States
Local Organizing Committee
Chairman  J. Desmond O’Duffy 
 Emre Kökmen 
Presentations by KSBD Members 
1. Clinical analysis of 57 cases of Behçet’s syndrome in children.
Moo Yon Cho, Sungnack Lee, Dongsik Bang, Eun-So Lee, Seung Hun Lee 
(Department of Dermatology, The Behçet’s Syndrome Specialty Clinic at Severance Hospital, 
Yonsei University College of Medicine, Seoul, Korea)
2. Prognostic comparison of Behçet’s disease with or without HLA-Bw51 antigen.
Man Soo Kim, Jae Ho Kim 
(Kangnam St. Mary’s Hospital, Catholic University Medical College, Seoul, Korea)
3. Sweet’s syndrome-like skin lesions in Behçet’s syndrome: An additional cutaneous manifestation.
Eun-So Lee, Seung Hun Lee, Dongsik Bang, Sungnack Lee 
(Department of Dermatology, The Behçet’s Syndrome Specialty Clinic at Severance Hospital, 
Yonsei University College of Medicine, Seoul, Korea)
4. Histopathological spectrum of erythema nodosum lesions in Behçet’s disease.
W. P. Daniel Su1, Soo Il Chun2, Sungnack Lee2, Roy S. Rogers III1 
(1Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA; 2Department of Dermatology, 
Yonsei University College of Medicine, Seoul, Korea)
5. Behçet’s syndrome and systemic lupus erythematosus: A case analysis.
Sungnack Lee, Eun-So Lee, Dongsik Bang, Seung Hun Lee, Chein-Soo Hong 
(Department of Dermatology, The Behçet’s Syndrome Specialty Clinic at Severance Hospital, 





6. Relationship of circulating immune complex levels with clinical activity in Behçet’s syndrome.
Oh Hun Kwon1, Hyun-Sook Kim1, Dong Soo Kim2, Eun-So Lee3, Seung Hun Lee3, Dongsik Bang3, 
Sungnack Lee3 
(Departments of 1Clinical Pathology, 2Pediatrics, and 3Dermatology, Yonsei University College of 
Medicine, Seoul, Korea)
7.  Evaluation of lymphocyte subpopulations in patients with Behçet’s syndrome showing low serum zinc 
levels.
Dongsik Bang, Yang An Kim, Sungnack Lee, Seung Hun Lee, Eun-So Lee 
(Department of Dermatology, The Behçet’s Syndrome Specialty Clinic at Severance Hospital, 
Yonsei University College of Medicine, Seoul, Korea)






6th International Conference on Behçet’s Disease
June 30-July 1, 1993
Paris, France
Local Organizing Committee
Chairman       Bertrand Wechsler 
 Pierre Godeau 
Presentations by KSBD members 
1.  Detection of herpes simplex virus DNA by polymerase chain reaction in saliva of patients with Behçet’s 
disease.
Eun-So Lee1, Sungnack Lee1, Dongsik Bang2, Young Ho Cho2, Seonghyang Sohn1 
(1Department of Dermatology, College of medicine, Ajou University, Suwon, and 2Department of 
Dermatology, Yonsei University College of Medicine, Seoul, Korea)
2. Prognosis of recurrent oral ulcerations in Behçet’s disease.
Eun-So Lee1, Won Hur2, Dongsik Bang2, Seung Hun Lee2, Sungnack Lee1, Hong Bok Kim3, 
Won Pyo Hong4 (1Department of Dermatology, College of medicine, Ajou University, Suwon, and 
2Department of Dermatology, 3Ophthalmology, and 4Otorhinolaryngology, Yonsei University College 
of Medicine, Seoul, Korea)
3.  The possible role of fat cells in the pathogenesis of erythema nodosum-like lesions of Behçet’s disease: 
An immunoelectron microscopic study.
Dongsik Bang1, Seonghyang Sohn2, Sungnack Lee2 
(1Department of Dermatology, Yonsei University College of Medicine, Seoul, and 2Department of 
Dermatology, College of medicine, Ajou University, Suwon, Korea)
4. The influence of pregnancy on Behçet’s disease.
Dongsik Bang1, Ik Byeong Haam1, Eun-So Lee2, Sungnack Lee2 
(1Department of Dermatology, Yonsei University College of Medicine, Seoul, and 2Department of 
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Chairman  M’hamed Hamza
Presentations by KSBD members 
1.  Abnormalities of T lymphocyte subsets and the binding of T lymphocyte to human dermal 
microvascular endothelial cells in Behçet’s disease patients.
D. Bang1, H.S. Kim1, K.H. Lee1, S. Lee2 
(1Department of Dermatology, Yonsei University College of Medicine, Seoul and 2Department of 
Dermatology, Ajou University School of Medicine, Suwon, Korea)
2. Behçet’s disease-like symptom induced by herpes simplex virus in ICR and several inbred mice.
S. Sohn1, E-S. Lee2, D. Bang3, S. Lee2 
(1Laboratory of Cell Biology, 2Department of Dermatology, Ajou University School of Medicine, 
Suwon and 3Department of Dermatology, Yonsei University College of Medicine, Seoul, Korea)
3.  Herpes simplex virus detection by polymerase chain reaction in intestinal ulcer of patients with Behçet’s 
disease.
E-S. Lee1, S. Lee1, D. Bang2, S. Sohn3 
(1Department of Dermatology, Ajou University School of Medicine, Suwon; 2Department of Dermatology, 
Yonsei University College of Medicine, Seoul and  3Laboratory of Cell Biology, Ajou University Institute of 
Medical science, Suwon, Korea)
4.  Detection of herpes simplex virus DNA by polymerase chain reaction in genital ulcer of patiens with 
Behçet’s disease.
D. Bang1,  Y.H. Cho1, H-J. Choi1, S. Lee2, S. Sohn3, E-S. Lee2 
(1Department of Dermatology, Yonsei University College of Medicine, Seoul; 2Department of 





University Institute of Medical science, Suwon, Korea)
5.  Ultrastructural changes of cultured human dermal microvascular endothelial cells (HDMEC) after 
treating with the sera of Behçet’s disease patients.
D. Bang1, K.H. Lee1, U.S. Choi1, E-S. Lee2, S. Lee2 
(1Department of Dermatology, Yonsei University College of Medicine, Seoul and 2Department of 
Dermatology, Ajou University School of Medicine, Suwon, Korea)
6. Vena cava syndrome in Behçet’s disease.
D. Bang1, M.S. Cha1, J.H. Yoo1, E-S Lee1, S. Lee2 
(1Department of Dermatology, Yonsei University College of Medicine, Seoul, and 2Department of 
Dermatology, Ajou University School of Medicine, Suwon, Korea)
7. Corticosteroid pulse therapy in neuro-Behçet’s disease.
D. Bang1, H.S. Lee1,  S. Lee2,  J.H. Heo3 
(1Department of Dermatology, Yonsei University College of Medicine, Seoul; 2Department of 
Dermatology Ajou University School of Medicine, Suwon and 3Department of Neurology, Yonsei 
University College of Medicine, Seoul, Korea)
Book cover of the Proceedings of the 7th 
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Presidents        I. Olivieri 
 R. Numo 
 C. Salvarini 
Presentations by KSBD Members 
1. Clinical comparison of recurrent aphthous ulcer and Behçet’s disease.
Dongsik Bang (Department of dermatology, Yonsei University College of Medicine, Seoul, Korea)
2. Role of macrophages and T cells in herpes simplex virus-induced Behçet’s disease mouse model.
Seonghyang Sohn1, Eun-So Lee2, Dongsik Bang3, Hyuk Jae Kwon1, Yun-Kyung Hur1,
 Sungnack Lee2 
(1Laboratory of Cell Biology, Ajou University Institute for Medical Sciences; 2Department of 
Dermatology, Ajou University School of Medicine, Suwon and 3Department of Dermatology, Yonsei 
University College of Medicine, Seoul, Korea)
3.  The effect of the serum from patients with Behçet’s disease on the expression of endothelial cell 
adhesion molecules and the adhesion of T-lymphocytes to vascular endothelial cells.
Kwang Hoon Lee1, Hae-Shin Chung1, Dongsik Bang1, Sungnack Lee2 
(1Department of Dermatology, Yonsei University College of Medicine, Seoul and 2Department of 
Dermatology, Ajou University School of Medicine, Suwon, Korea)
4.  Lower extremity vascular involvement of Behçet’s disease not showing significant clinical manifestation 
visualized by doppler ultrasonography.
Eun-So Lee1, Kyung Il Chung2, Sungnack Lee1 
(1Department of Dermatology, Ajou University School of Medicine, Suwon and 2Department of 





5. Experimental studies of antiviral agent-famciclovir in Behçet’s disease symptoms of ICR mice.
Seonghyang Sohn1, Dongsik Bang2, Eun-So Lee3, Hyuk Jae Kwon1, Seung Ihm Lee1, Sungnack Lee3 
(1Laboratory of Cell Biology, Ajou University Institute for Medical Sciences; 2Department of Dermatology, 
Yonsei University College of Medicine, Seoul and 3Department of Dermatology, Ajou University School 
of Medicine, Suwon, Korea)
6. Clinical manifestations of late-onset Behçet’s disease.
Sungnack Lee1, Eun-So Lee1, Dongsik Bang2, Jae Bok Jun3 
(1Department of Dermatology, Ajou University School of Medicine, Suwon, Korea; 2Department 
of Dermatology, Yonsei University College of Medicine, Seoul and 3Department of Dermatology, 
Kyungpook National University School of Medicine, Taegu, Korea)
Professor Thomas Lehner, Mrs. Barnes, Dr. Colin Barnes, 
Professors Sungnack Lee and Dongsik Bang at the 8th 
International Conference on Behçet’s Disease






9th International Conference on Behçet’s Disease
May 27-29, 2000
Hilton Hotel, Seoul, Korea
Local Organizing Committee
President Sungnack Lee 
Secretary General Dongsik Bang 
ISBD Executive Committee   
President  Colin G. Barnes (UK)
Vice-President Sungnack Lee (Korea)
Secretary Hasan Yazici (Turkey)  
[ The significance of the 9th ICBD in Seoul]
The 9th International Conference on Behçet’s Disease was held in Seoul from May 27 to May 29, 2000 
(President of the 9th International Conference on Behçet’s Disease: Sungnack Lee, Dr. med. habil.). Seoul 
became the second Asian city to host the Conference since its premiere in 1964. 
In the 9th International Conference on Behçet’s Disease, more than 250 Behçetologists from twenty-
three different nations around the world gathered in Seoul and presented 175 different topics. On May 27, 
the opening day, President Sungnack Lee of the Conference, President Je G. Chi of the Korean Medical 
Association, and Turkish Ambassador Mr. Halil Dag gave their congratulatory addresses. There were 
visible advancements in the fields of Immunology and Molecular Genetics. Also, future possibilities of gene 
therapy of Behçet’s disease were shown. On the last day of the conference, as the representative of all patients 
with Behçet’s disease, Dr. T. Nishida from Japan and his father Mr. N. Nishida, gave their presentation 
entitled “The First International Convention for Patients with Silk Road Disease (Behçet’s Disease)”.
The most meaningful event at the Conference was that the former “International Study Group for 
Behçet’s Disease” was reborn as the “International Society of Behçet’s Disease.” The inaugural meeting 
of the International Society of Behçet’s Disease provided a blueprint for future plans, including the 





Presentations by KSBD Members 
1. Behçet’s disease or Behçet’s syndrome: Considerations for the unified diagnosis related terminology.
Sungnack Lee (Department of Dermatology, Ajou University School of Medicine, Suwon, Korea)
2. Prevalence estimation of Behçet’s disease in Korea. 
Jaehoon Roh1, Jong-Uk Won1, Jaeseok Song1, Chinyon Kim2, Yousook Whang2, Changsoo Kim1 
(1Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea and 
2Center for Occupational Health, Severance Hospital, Seoul, Korea)
3. Behçet’s disease: The first Mongolian case in literature showing HLA B51, MICA gene type *5/*6.
Yae Lee Chung1, Dongsik Bang1, Eun-So Lee2, Sungnack Lee2, Jeewon Mok3, Kyung Sook Park3 
(1Department of Dermatology, Yonsei University College of Medicine, Seoul; 2Department of 
Dermatology, Ajou University School of Medicine, Suwon and 3Department of Dermatology, 
Sungshin Women’s University, Seoul, Korea)
4. The significance of laboratory tests in evaluating the clinical activity of Behçet’s disease.
Dongsik Bang1, Hyoung Sup Kim1, Eun-So Lee2, Sungnack Lee2 
(1Department of Dermatology, Yonsei University College of Medicine, Seoul and 2Department of 
Dermatology, Ajou University School of Medicine, Suwon, Korea)
5.  Clonal proliferation of B cell bearing immunoglobulin γ heavy chain in the synovium of Behçet’s 
disease with arthritis.
Chang-Hee Suh, Yong-Beom Park, Chang-Ho Song, Jungsik Song, Won-Ki Lee, Chan-Hee Lee, 
Soo Kon Lee 
(Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, 
Seoul, Korea)
6.  TH1/TH2 cytokines regulate the development and improvement of Behçet’s disease induced by herpes 
simplex virus inoculation in mouse model.
Seonghyang Sohn1, Seung Ihm Lee1, Hyuk Jae Kwon1, Eun-So Lee2, Dongsik Bang3, Sungnack Lee3
(1Laboratory of Cell Biology, Ajou University Institute for Medical Sciences; 2Department of 
Dermatology, Ajou University School of Medicine, Suwon and 3Department of Dermatology, Yonsei 
University College of Medicine, Seoul, Korea)





influence the expressions of cytokines.
Seonghyang Sohn1, Seung Ihm Lee1, Hyuk Jae Kwon1, Eun-So Lee2, Jang Hyun Kim3, Jee Yong Ha4, 
Suh Young Choi5, Dongsik Bang6, Sungnack Lee2
(1Laboratory of Cell Biology, Ajou University Institute for Medical Sciences; 2Department of 
Dermatology, Ajou University School of Medicine, Suwon; 3Dongguk University College of Oriental 
Medicine; 4Sangji University College of Oriental Medicine; 5Hana Medical Foundation, Korea and 
6Department of Dermatology, Yonsei University College of Medicine, Seoul, Korea)
8.  Signal transduction pathway in activation of endothelial cells by antiendothelial cell antibodies in sera 
of patients with Behçet’s disease.
Heun-Jung Cho1, Dongsik Bang1, Sungnack Lee2, Won-Jae Lee3, Kwang Hoon Lee1 
(1Department of Dermatology, Yonsei University College of Medicine, Seoul; 2Ajou University School 
of Medicine, Suwon  and 3Laboratory of Immunology, Medical Research Center, Yonsei University 
College of Medicine, Seoul, Korea)
9.  Increased expression of inducible nitric oxide synthase and appearance of dark cell degeneration in 
blood vessels of erythema nodosum-like lesions in Behçet’s disease: A study by immunohistochemistry 
and electron microscopy.
Takayoshi Honma1, Dongsik Bang2, Sungnack Lee3 
(1Department of Pharmacology, Kawasaki Medical school, Kurashiki, Japan; 2Department of 
Dermatology, Yonsei University College of Medicine, Seoul and 3Department of Dermatology, Ajou 
University School of Medicine, Suwon, Korea)
10. Dermatologic manifestations of Behçet’s disease.
Dongsik Bang1, Eun-So Lee1, Sungnack Lee2 
(1Department of Dermatology, Yonsei University College of Medicine, Seoul and 2Department of 
Dermatology, Ajou University School of Medicine, Suwon, Korea)
11. A study on the effects of local factors on the oral ulcers observed in Behçet’s disease.
Hyoung-Joon Ahn, Myoun-Chan Kim, Jong-Hoon Choi, Chong-Youl Kim 
(Department of Oral Medicine, College of Dentistry, Yonsei University, Seoul, Korea)
12.  Histopathologic findings in genital ulcer of Behçet’s disease: Immunological studies of genital ulcer in 





Min Kim, Jee-Bum Lee, Seung-chul Lee, Young Ho Won 
(Department of Dermatology, Chonnam University Medical School, Kwangju, Korea)
13. Sweet’s syndrome-like skin lesion associated with Behçet’s disease.
KH Cho, WW Choi, HC Eun    
(Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea)
14. Surgical experience of Behçet’s disease involving cardiovascular system.
Young Tae Kwak1, Jin Gu Lee1, Byung Chul Chang1, Jong Won Ha2, Seung Yun Cho2, Bum Koo Cho1 
(1Division of Cardiovascular Surgery and 2Division of Cardiology, Yonsei Cardiovascular Center, 
College of Medicine, Yonsei University, Seoul, Korea)
15. Aortic valve involvement in Behçet’s disease.
Choong Won Lee1, Jisoo Lee2,  Won Ki Lee2, Chan Hee Lee2, Chang Hee Suh2, Chang Ho Song2, 
Yong Beom Park2, Soo Kon Lee2, Yong Soon Won3 
(1Division of Rheumatology, Department of Internal Medicine, Wallace Memorial Baptist Hospital, 
Pusan; 2Department of Internal Medicine, Yonsei University College of Medicine, Seoul and 
3Department of Thoracic Cardiovascular Surgery, Ewha University, Seoul, Korea)
16. Thrombosis in patients with Behçet’s disease in Korea.
Seong Wook Kang1, Ki Chul Shin2, Yun Jong Lee2, Eun Bong Lee2, Han Joo Baek2, Han Joo Baek2, 
Hyun Ah Kim2, Young Wook Song2 
(1Department of Internal Medicine, Chungnam National University Hospital, Taejon and 
2Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea)
17. Screening with lung perfusion scan for vasculitis in Behçet’s disease.
BW Choi1, KO Choe1, YK Hong1, JD Lee1, D Bang2    
(1Department of Diagnostic Radiology, Research Institute of Radiological Science, Yonsei University 
College of Medicine, Seoul and 2Department of Dermatology, Yonsei University College of Medicine, 
Seoul, Korea)
18. The prevalence of lower intestinal involvement in Behçet’s disease.
Young Mo Kang1, Gun Woo Kim1, Han Ik Bae2, Nung Soo Kim1, Jae Bok Jun3 
(1Department of Internal Medicine, 2Department of Pathology, and 3Department of Dermatology, 





19. Colonoscopic findings in intestinal Behçet’s disease.
Won Ho Kim1, Yong Suk Cho1, Chung Ryul Lee1, In Suh Park1, Dongsik Bang2 
(1Departments of Internal Medicine and 2Dermatology, Yonsei University College of Medicine, 
Seoul, Korea)
20. Differentiation of intestinal Behçet’s disease and Crohn’s disease by colonoscopic findings.
Chung Tyul Lee1, Won Ho Kim1, Yong Suk Cho1, Jin Kyung Kang1, Jong Keun Lim2 
(1Department of Internal Medicine and 2Department of Medical Statistics, Yonsei University College 
of Medicine, Seoul, Korea)
21. Longterm outcome of surgical resection for intestinal involvement in Behçet’s disease.
Nam Kyu Kim1, Won Ho Kim2, Jae Kun Park1, Seong Hyeon Yun1, Jin Sik Min1 
(1Departments of Surgery and 2Internal Medicine, Yonsei University College of Medicine, Seoul, Korea)
22.  Pathologic manifestations of Behçet’s enteritis: analysis of 5 macroscopic, 5 microscopic and 5 negative 
findings in 16 resected cases.
Yong Il Kim, Woo Ho Kim, Hye Seung Lee 
(Department of Pathology, Seoul National University, Seoul, Korea)
23. Ophthalmologic manifestations of Behçet’s disease in Korea.
Hyoung Jun Koh, Bong Kyun Kim, Soon Hyun Kim, Hong Bok Kim
(Institute of Vision Research and Department of Ophthalmology, Yonsei University College of Medicine, 
Seoul, Korea)
24. Graded treatment of Behçet’s disease.
Yun-Woo Lee1, Hong-Joon Ahn2, Seong-Hoon Han3 
(Department of Internal Medicine, Inje University College of Medicine, at 1Ilsan Paik hospital, 
Koyang, Kyunggi; 2Seoul Paik hospital, Seoul and 3Sanggyae Paik hospital, Seoul, Korea)
25. Ten cases of Behçet’s disease associated with tumor.
Dongsik Bang1, Jung-Ho Lee1, Eun-So Lee2, Sungnack Lee2 
(1Department of Dermatology, Yonsei University College of Medicine, Seoul and 2Department of 
Dermatology, Ajou University School of Medicine, Suwon, Korea)
26. The effects of Behçet’s disease on bone mineral density.





(1Department of Internal Medicine, Yonsei University College of Medicine and 2Department of 
Dermatology, Yonsei University College of Medicine, Seoul, Korea)
27. Epidemiologic and clinical survey of Behçet’s disease in Korea: The first multicenter study.
The Korean study group for Behçet’s disease: D.Bang1, J.H.Lee1, E.-S.Lee2, S.Lee2, J.S.Choi3,
Y.K.Kim4, B.K.Cho5, J.K.Koh6, S.E.Chang6, Y.H.Won7, N.I.Kim8, S.D.Park9, H.J.Ahn10, Y.W.Lee11,
H.Y.Wang12, W.W.Lee13, H.C.Eun14, E.S.Song15, S.W.Lee16, C.W.Lee17, C.J.Lee18, S.Y.Kim18, J.H.Park19,
 Y.W.Song20, S.T.Kim21, C.Y.Kim22, J.S.Kim23, J.H.Lee23, K.S.Kwon24, B.K.Kim24
(1Department of Dermatology, Yonsei University College of Medicine; 2Department of Dermatology, 
Ajou University School of Medicine; 3Department of Dermatology, College of Medicine, Yeungnam 
University; 4Department of Dermatology, College of Medicine, Inha University; 5Department of 
Dermatology, St. Mary’s Hospital, the Catholic university of Korea; 6Department of Dermatology, 
Asan Medical Center, University of Ulsan College of Medicine; 7Department of Dermatology, 
Chonnam National University Medical School; 8Department of Dermatology, College of Medicine, 
Kyung Hee University; 9Department of Dermatology, Wonkwang University School of Medicine; 
10Department of Internal Medicine, Seoul Paik Hospital, Inje University School of Medicine; 
11Department of Rheumatology, Ilsan Paik Hospital, Inje University School of Medicine; 
12Department of Dermatology, Pusan Paik Hospital, Inje University School of Medicine; 
13Department of Dermatology, Maryknoll Hospital; 14Department of Dermatology, Seoul National 
University College of Medicine; 15Department of Dermatology, Chonju Presbyterian Medical Center; 
16Department of Rheumatology, Dong-A Medical College; 17Department of Dermatology, Hanyang 
University  Medical College; 18Department of Dermatology, Kangdong Sacred Heart Hospital, 
Hallym University Medical College; 19Department of Rheumatology, Keimyung University Dongsan 
Medical Center; 20Department of Rheumatology, Seoul National University College of Medicine; 
21Department of Dermatology, Kosin Medical University & Gaspel Hospital; 22Department of Oral  
Medicine, Yonsei University College of Dentistry; 23Department of Dermatology, Chungnam National 
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10th International Conference on Behçet’s Disease
June 27-29, 2002
University Medical Center Benjamin Franklin, the Free University of Berlin, 
Berlin, Germany 
Local Organizing Committee
President         Christos C. Zouboulis 
ISBD Executive Committee
President  Colin G. Barnes (UK)
Vice President Sungnack Lee (Korea)
Honorary Secretary, President-Elect Hasan Yazici (Turkey) 
Presentations by KSBD members 
1. Influence of sex on patients with Behçet’s disease in Korea.
Dongsik Bang1, Sang Ho Oh1, Kwang Hoon Lee1, Eun-So Lee2, Sungnack Lee2 
(1Department of Dermatology, Yonsei University College of Medicine, Seoul and 2Department of 
Dermatology, Ajou University School of Medicine, Suwon, Korea)
2. Development of clinical activity form for Korean patients with Behçet’s disease.
E-S. Lee1, H.S. Kim2, D. Bang2, H.G. Yu3, H. Chung3, D.H. Shin4, Y.W. Song4, Y.B. Park5, S.K. Lee5,
S.K. Shin6, W.H. Kim6, J.H. Choi7, B.J. Park7, S. Lee1 
(1Department of Dermatology, Ajou University School of Medicine, Suwon; 2Department of 
Dermatology, Yonsei University College of Medicine, Seoul; 3Department of Ophthalmology, Seoul 
National University College of Medicine; 4Department of Rheumatology, Seoul National University 
College of Medicine; 5Department of Rheumatology, Yonsei University College of Medicine; 
6Department of Gastrointestinal Medicine, Yonsei University College of Medicine and 7Department 
of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea)





Kwang Hoon Lee1, Hongsuk Kim1, Sungnack Lee2, Dongsik Bang1 
(1Department of Dermatology, Yonsei University College of Medicine, Seoul and 2Department of 
Dermatology, Ajou University School of Medicine, Suwon, Korea)
4.  The ICAM1469*E is associated with susceptibility to ocular lesions and vasculitis in Korean patients 
with Behçet’s disease.
Eun Hee Kim1, Jee Won Mok1, Dongsik Bang2, Eun-So Lee3, Sungnack Lee3, Kyung Sook Park1 
(1Department of Biology, Sungshin Women’s University, Seoul; 2Department of Dermatology, Yonsei 
University College of Medicine, Seoul and 3Department of Dermatology, Ajou University School of 
Medicine, Suwon, Korea)
5.  Cytokine production of peripheral blood mononuclear cells stimulated with Streptococcus sanguis 
antigen in patients with Behçet’s disease.
Kwang Hoon Lee1, Hyoung Sup Kim1, Fumio Kaneko2, Dongsik Bang1 
(1Department of Dermatology, Yonsei University College of Medicine, Seoul, Korea and 
2Department of Dermatology, Fukushima Medical College, Fukushima, Japan)
6. Clinical features of Behçet’s disease patients with epididymitis.
Dongsik Bang1, Young-Hun Cho1, Jeanne Jung1, Kwang Hoon Lee1, Eun-So Lee2, Sungnack Lee2 
(1Department of Dermatology, Yonsei University College of Medicine, Seoul and 2Department of 
Dermatology, Ajou University School of Medicine, Suwon, Korea)
7.  Therapeutic effect of thalidomide through cytokine and chemokine regulation in herpes simplex virus-
induced Behçet’s disease-like animal model.
Seonghyang Sohn1, Eun-So Lee2, Seung Ihm Lee1, Youngae Kim1, Hyuk Jae Kwon1, Dongsik Bang3, 
Sungnack Lee2 
(1Laboratory of Cell Biology, Ajou University Institute for Medical Sciences; 2Department of 
Dermatology, Ajou University School of Medicine, Suwon and 3Department of Dermatology, Yonsei 





Professors Fumio Kaneko, Dongsik Bang, Sungnack Lee, Eun-So Lee, Seonghyang Sohn, and 
Shigeaki Ohno at the 10th International Conference on Behçet’s Disease






11th International Conference on Behçet’s Disease 
October 27-31, 2004






President  Colin G. Barnes (UK)
Vice President Sungnack Lee (Korea)
Secretary Hasan Yazici (Turkey) 
Presentations by KSBD Members
1.  The cross-reactivity of anti human α-enolase antibody in the sera of Behçet’s disease patients to 
Streptococcus sanguis antigen.
Chang J.Y., Wu W.H., Lee J.H., Bang D., Lee K.H.
2.  Expression of chemokines in patients with Behçet’s disease in relation to clinical activity.
Heo J.H., Sohn S., Lee S., Lee E.-S.
3. HLA-G 3741 14bp insertion in the 3’-UTR in Behçet’s disease.
Choi J.S., Nam J.H., Bang D., Lee E.-S., Lee S., Park K.S.
4. Genitourinary involvement in Behçet’s disease.
Bang D., Lee H.J., Lee K.-H., Lee E.-S., Lee S.
5. HYPA haplotype in the mannose binding lectin gene (MBL2) is associated with Behçet’s disease.
Park K.S., Min K., Nam J.H., Bang D., Lee E.S., Lee S.
6. Anti-α-enolase antibody in sera from patients with Behçet’s disease and rheumatologic disorders.





7.  Anti-α-enolase antibody in sera from patients with gastrointestinal Behçet’s disease and chronic 
inflammatory bowel disease.
Chang J.Y., Lee J.H., Bang D., Ha K.W., Choi C.H., Kim W.H., Lee K.H.
8. The effects of in vivo irradiation on the cytokine production in Behçet’s disease-like mice.
Sohn S., Kang S., Lee E.-S., Choi B., Lim H., Bang D., Chun M., Lee S.
9. Expression of neuropeptides in Behçet’s disease in relation to clinical activity.
Jang Y.H., Lee S., Lee E.-S.
10. Two cases of pediatric Behçet’s disease with colon lesions as the initial symptom.
Kim D.S., Choi K.M.
11. Unusual cases of Behçet’s disease combine with fistula and poor prognosis.
Bang D., Chung H.J., Goo B.C., Lee J.H., Lee K.H., Lee E.-S., Lee S.
12. Audio-vestibular involvement in patients with Behçet’s disease.
Choung Y.-H., Lee E.-S., Park K., Lee J.
13. Coexistence of Behçet’s disease and autoimmune disease: Clinical features of 11 patients.
Cho S.B., Bang D., Lee K.H., Lee E.-S., Lee S.
Abstract cover of the 11th International Conference 
on Behçet’s Disease
Professor Dongsik Bang at the 11th International 





12th International Conference on Behçet’s Disease
September 19-23, 2006
Corinthia Alfa hotel, Lisbon, Portugal 
Local Organizing Committee
President         Jorge Crespo 
Vice-President Rui Proença 
Secretary General José Vaz Patto 
ISBD Executive Committee
President  Hasan Yazici (Turkey)
Vice President Sungnack Lee (Korea)
Secretary Vedat Hamuryudan (Turkey) 
Presentations by KSBD Members 
1. Expression of macrophage migration inhibitory factor in Behçet’s disease.
In Sung-Il1, Baek Jin Ah2, Park Kyung Sook2, Bang Dongsik3, Lee Eun-So1
(1Dermatology, Ajou University School of Medicine, Suwon; 2Biology, Sungshin Women’s University, 
Seoul, Korea and 3Dermatology, Yonsei University College of Medicine, Seoul, Korea)
2. TNF alpha siRNA regulates Behçet’s disease-like symptoms in a mouse model.
Sohn S1, Hwang Y1, Choi B1, Kwon HJ1, Lee ES1, Park KS2, Bang D3, Lee S4 
(1Laboratory of Cell Biology, Ajou University Institute for Medical Sciences; 2Department of Biology, 
Sungshin Women’s University; 3Department of Dermatology, Yonsei University College of Medicine, 
Seoul; and 4Department of Dermatology, Gachon University, School of Medicine, Incheon, Korea)
3. The role of Qa-2, the functional homolog of HLA-G, in Behçet’s disease-like mice.
Sohn S1, Lee M1, Kwon HJ1, Park KS2, Lee ES1 
(1Laboratory of Cell Biology, Ajou University Institute for Medical Sciences; and 2Department of 





4.  Synthesized pyridine compound derivatives decreased TNF alpha in vitro and in vivo and ameliorated 
Behçet’s disease-like symptoms in mice.
Sohn S1, Choi B1, Kwon HJ1, Kim JH2, Lee ES1, Lee S3 
(1Laboratory of Cell Biology, Ajou University Institute for Medical Sciences; 2SK Chemicals and 
3Department of Dermatology, Gachon University, School of Medicine, Incheon, Korea)
5. HLA-E and HLA-G variants increase the risk for Behçet’s disease.
Park JS1, Nam JH1, Bang D2, Lee ES3, Sohn S4, Park KS1 
(1Department of Biology, Sungshin Women’s University; 2Department of Dermatology, Yonsei 
University College of Medicine, Seoul; 3Department of Dermatology, Ajou University School of 
Medicine; 4Laboratory of Cell Biology, Ajou University Institute for Medical Sciences, Suwon, Korea)
6. The Behçet’s disease quality of life (BD-QoL): Reliability and validity of the Korean version.
Sang Won Yi1, Ji Hae Kim2, Ki Young Lim3, Dongsik Bang4, Sungnack Lee5, Eun-So Lee1 
(1Department of Dermatology, Ajou University School of Medicine, Suwon; 2Department of 
Psychiatry, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul; 
3Department of Psychiatry, Ajou University School of Medicine, Suwon; 4Department of 
Dermatology, Yonsei University College of Medicine, Seoul; 5Department of Dermatology, Gachon 
University of Medicine and Science, Incheon, Korea)
7. Methylenetetrahydrofolate reductase gene C677T mutation in recurrent aphthous stomatitis.
Roh JY1, Kim M1, Baek JO1, Yoon ST3, Lee S1, Im JS2
(1Department of Dermatology; 2Department of Preventive Medicine, Gachon University of Medicine 
and Science and 3Gachon University Graduate school of Public Health, Incheon, Korea)
8.  Chemokines and chemokine receptors of intraocular lymphocytes in patients with Behçet’s and non-
Behçet’s uveitis.
Tae Wan Kim1,2, Jae Kyoun Ahn3, Hum Chung1, Suh Young Lee1,2, Hyeong Gon Yu1,2 
(1Department of Ophthalmology, Seoul National University College of Medicine; 2Medical Research Center, 
Seoul National University and 3Department of Opthalmology, Chonnam National University Hospital)
9. Stepwise immunomodulatory treatment and visual prognosis in patients with Behçet uveitis.
Hyeong Gon Yu1, Sang Jin Kim1, Jun Soon Kim1, Jong Mo Seo1,2, Hum Chung1 





Center, Seoul National University)
10. Leg ulcers in Behçet’s disease.
Jin Young Jung, Do Young Kim, Jae Yong Chang, Ju Hee Lee, Kwang Hoon Lee, Dongsik Bang 
(Department of Dermatology and Cutaneous Biology Research Institute, Yonsei University College 
of Medicine, Seoul, Korea)
11. Two cases of pancytopenia induced by colchicines use with immunosuppressant in Behçet’s disease.
Sungnack Lee1, Kyu-yeop Lee2, Jin Young Jung2, Ju Hee Lee2, Kwang Hoon Lee2, Dongsik Bang2 
(1Department of Dermatology, Gachon University of Medicine and Science, Incheon and 
2Department of Dermatology and Cutaneous Biology Research Institute, Yonsei University College 
of Medicine, Seoul, Korea)
12. The effect of topical 0.2% hyaluronic acid gel on recurrent oral ulcer.
Ju Hee Lee, Kyu-yeop Lee, Jin Young Jung, Dongsik Bang 
(Department of Dermatology and Cutaneous Biology Research Institute, Yonsei University College 
of Medicine, Seoul, Korea)
13.  Identification of disease-specific proteins reacting with sera from Behçet’s disease, systemic lupus 
erythematosus, dermatomyositis, rheumatoid arthritis, and Takayasu’s arteritis patients.
Ju Hee Lee1, Dongsik Bang1, Soo Kon Lee2, Nam Soo Chang1, Kwang Hoon Lee1 
(1Department of Dermatology and Cutaneous Biology Research Institute, Yonsei University College 
of Medicine,  and 2Division of Rheumatology, Department of Internal Medicine, Yonsei University 
College of Medicine, Seoul, Korea)
14.  The cross-reactivity of anti huma alpha-enolase antibody to various streptococcus and staphylococcus.
Ju Hee Lee1, Wen Hao Wu1, Jae Yong Chang1, Jin Wou Kim2, Dongsik Bang1, Kwang Hoon Lee1 
(1Department of Dermatology and Cutaneous Biology Research Institute, Yonsei University College 
of Medicine, Seoul and 2Department of Dermatology, Uijeongbu St. Mary’s Hospital, Medical 
College, The Catholic University of Korea, Uijeongbu, Korea)
15. Role of interleukin-23 in the pathogenesis of Behçet’s disease.
Jin Young Jung, Jae Yong Chang, Wook Lew, Dongsik Bang 
(Department of Dermatology and Cutaneous Biology Research Institute, Yonsei University College 





16. Visual prognosis and risk factors for Korean patients with Behçet’s uveitis.
Sung Chul Lee, Young Jae Cho, Suk Ho Byeon, Hyoung Jun Koh, Oh Woong Kwon 
(The Institute of Vision Research and Department of Opthalmology, Yonsei University College of 
Medicine, Seoul, Korea)
17. Clinical significance of erythema nodosum-like skin lesion in Behçet’s disease.
Dongsik Bang 
(Department of Dermatology and Cutaneous Biology Research Institute, Yonsei University College 
of Medicine, Seoul, Korea)
Abstract cover of the 12th International Conference on 
Behçet’s Disease
Professor Dongsik Bang at the 12th International 
Conference on Behçet’s Disease in Lisbon, Portugal
Professors Dongsik Bang and Ju Hee Lee at the 12th 





13th International Conference on Behçet’s Disease 
May 24-27, 2008
Congress Center Wörthersee, Portschach / Klagenfurt, Austria
Local Organizing Committee
President         Michael Schirmer 
Secretary C. Dejaco
 C. Duftner
 M. Kriessmayr-Lungkofler 
ISBD Executive Committee 
President  Hasan Yazici (Turkey) 
President-Elect Sungnack Lee (Korea)
Vice President Kenneth Calamia (USA)
Secretary Vedat Hamuryudan (Turkey) 
Presentations by KSBD Members
1. Coexistence of Behçet’s disease and cutaneous polyarteritis nodosa.
E.C. Han, S.H. Oh, D. Bang 
2. Therapeutic effects of topical tacrolimus for mucosal lesion of Behçet’s disease.
J.Y. Rho, S.Y. Na, H.Y. Lee, J.O. Baek, J.R. Lee
3. Chemokines environment of intraocular lymphocytes in patients with Behçet’s and non-Behçet’s 
uveitis.
W. Kim, H. Chung, H.G. Yu
4. Visual outcome in Korean Behçet’s patients with uveitis.
H.G. Yu, T.W. Kim, H. Chung
5.  Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behçet’s 
disease.





6. CTLA-4 gene polymorphisms and natural soluble CTLA-4 protein in Behçet’s disease.
K.S. Park, J.A. Baek, S.Y. Kwon, D. Bang, E.-S. Lee
7. Expression of TIM-3 and its role in pathogenesis of Behçet’s disease.
J.S. Lee, S. Park, E.-S. Lee
8.  Interleukin-6 small interfering RNA decrease mucocutaneous symptoms in a Behçet’s disease mouse 
model.
J. Shim, H. Byun, Y. Lee, E. Lee, D. Bang, S. Lee, S. Sohn
9.  Rebamipide affects the efficiency of colchicine for the Herpes Simplex Virus-induced inflammation in 
a Behçet’s disease mouse model.
S. Sohn, D. Bang, B. Choi, H.J. Kwon, E.-S. Lee, S. Lee
10. Th17 associated cytokine profile in cutaneous lesion of Behçet’s disease.
K.-Y. Lee, E.C. Han, W. Lew, S.H. Oh, J.H. Lee, D. Bang
11. Evaluation of articular involvement of Behçet’s disease via bone scintigraphy.
E.C. Han, S.H. Oh, K.-Y. Lee, J.H. Lee, D. Bang
12. Clinical manifestations associated with high titer of Anti-Streptolysin O in Behçet’s disease.
S.H. Oh, K.-Y. Lee, J.H. Lee, D. Bang






Group photo at the 13th International Conference on Behçet’s Disease
Congress Center Wörthersee, Portschach, venue of the 13th International 
Conference on Behçet’s Disease, Klagenfurt, Austria






14th International Conference on Behçet’s Disease
July 8-10, 2010
Queen Mary University of London Mild End Campus, London, United Kingdom
Local Organizing Committee
President          Dorian Haskard 
International Affairs Secretary Colin G. Barnes 
Secretary General  Graham Wallace 
ISBD Executive Committee 
President   Sungnack Lee (Korea)
Vice President  Kenneth Calamia (USA)
Secretary  Dongsik Bang (Korea)
Invited Speaker
Perspective of candidate gene analysis in Behçet’s disease
Eun-Bong Lee
 (Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea)
Presentations by KSBD Members
1. Altered expression of costimulatory molecules in Behçet’s disease according to clinical activity.
Ji Hyun Han1, Mi Jin Park1, Sun Park2, Eun-So Lee1 
(1Department of Dermatology, Ajou Univerity School of Medicine and 2Department of Microbiology 
Ajou University School of Medicine, Suwon, Korea)
2.  Expression of pro-inflammatory protein S100A12 (EN-RAGE) in Behçet’s disease and its association 
with disease activity.
Eun Chun Han1, Sung Bin Cho1, Keun-jae Ahn1, Sang Ho Oh1, Jihyun Kim1, Dong Soo Kim2,  
Kwang Hoon Lee1, Dongsik Bang1 





of Medicine and 2Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea)
3. Genome-wide association studies define two susceptibility loci for Behçet’s disease.
Nobuhisa Mizuki1, Akira Meguro1, Masao Ota2, Yeong Wook Song3, Eun Bong Lee3, 
Nobuyoshi Kitaichi4, Kenichi Namba5, Yukihiro Horie5, Mitsuhiro Takeno6, Sunao Sugita7, 
Manabu Mochizuki7, Seiamak Bahram8, Yoshiaki Ishigatsubo6, Hidetoshi Inoko9, Shigeaki Ohno10 
(1Department of Ophthalmology and Visual Science, Yokohama City University Graduate 
School of Medicine; 2Department of Legal Medicine, Shinshu University School of Medicine; 
3Department of Internal Medicine, Seoul National University College of Medicine; 4Department 
of Ophthalmology, Health Sciences University of Hokkaido; 5Department of Ophthalmology and 
Visual Sciences, Hokkaido University Graduate School of Medicine; 6Department of Internal 
Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine; 
7Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University Graduate 
School of Medicine; 8Laboratoire D’immugenetique Moleculaire Humaine, Centre de Recherche 
d’immunologie et d’Hematologie, Faculte de Medecine, Universite de Strasbourg; 9Department 
of Molecular Life Science, Division of Molecular Medical Science and Molecular Medicine, Tokai 
University School of Medicine; 10Department of Ocular Inflammation and Immunology, Hokkaido 
University Graduate School of Medicine)
4.  TIM3-TIM3 Ligand interaction ameliorate herpes simplex virus-induced Behçet’s disease-like 
symptoms. 
Ju A Shim1, Sun Park2, Eun-So Lee3, Toshiro Niki4, Mitsuomi Hirashima5, Seonghyang Sohn1
(1Lab of Cell Biology, 2Department of Microbiology, 3Department of Dermatology, Ajou University 
School of Medicine, Suwon, Korea, 4GalPharma Co. Ltd, and 5Department of Immunology and 
Immunopathology, Kagawa University, Kagawa, Japan)
5.  Vitamin D3 ameliorated the inflammation in herpes simplex virus induced Behçet’s disease-like mouse 
model through down-regulation of toll-like receptors. 
Bunsoon Choi1, Eun-So Lee2, Dongsik Bang3, Seonghyang Sohn1 
(1Lab of Cell Biology, 2Department of Dermatology, Ajou University School of Medicine, Suwon, 
Korea and 3Department of Dermatology and Cutaneous Biology Research Institute, Yonsei 





Abstract cover of the 14th International Conference on 
Behçet’s Disease
Dinner at the 14th International Conference on Behçet’s 
Disease
The Queen Mary University of London, Mile End Campus, 
venue of the 14th International Conference on Behçet’s 
Disease, United Kingdom in 2010
Professors Dongsik Bang and Sung Bin Cho at the 14th 
International Conference on Behçet’s Disease
Professor Sungnack Lee at the 14th International 





15th International Conference on Behçet’s Disease
July 13-15, 2012
Yokohama Convention Center, Yokohama, Japan
Local Organizing Committee
President         Yoshiaki Ishigatsubo 
Secretary General Mitsuhiro Takeno 
ISBD Executive Committee 
President  Sungnack Lee (Korea)
Vice President Dorian Haskard (UK)
Secretary Dongsik Bang (Korea)
Presentations by KSBD Members
1.  The sera of patients with Behçet’s disease and Streptococcus sanguis stimulate membrane expression of 
HnRNP A2/B1 in HDMECs.
Sung Bin Cho, Zhenlong Zheng, Do Young Kim, Suhyun Cho, Min Ju Choi, Kwang Hoon Lee, 
Dongsik Bang 
(Department of Dermatology and Cutaneous Biology Institute, Yonsei University College of 
Medicine, Seoul, Korea)
2. Changes in the intraocular cytokine levels after intravitreal bevacizumab in uveitic macular edema.
Sohee Jeon, Won Ki Lee 
(Ophthalmology, Seoul Saint Mary’s hospital, Korea)
3. Targeted sequencing of candidate genes in Behçet’s disease.
Hyeong Gon Yu1, Sang Jin Kim1, Hee Yoon Cho2, Jae Suk Kim3, Hum Chung1 
(1Department of Ophthalmology, Seoul National University College of Medicine & Medical Research 
Center, Seoul National University, Korea; 2Department of Ophthalmology, Hanyang University 





4. Alpha-enolase expression on the surfaces of monocytes in patients with Behçet and non-Behçet uveitis.
Tae Wan Kim1,2, Jae Seung Kang3, Jeeyun Ahn1,2, Hum Chung2, Hyeong Gon Yu2 
(1Department of Ophthalmology, Seoul Metropolitan Government Seoul National University 
Boramae Medical Center, Korea; 2Department of Ophthalmology, Seoul National University College 
of Medicine and 3Department of Anatomy and Tumor Immunity Medical Research Center Seoul 
National University College of Medicine)
5.  Epidemiological and clinical characteristics of Behçet’s disease in Korea – using a clinical database for 
patients’ registry.
So Young Na1, Ji-Hye Park1, Sung Bin Cho2, Suhyun Cho2, Dongsik Bang2, Joo Young Rho3, 
Hyeong Gon Yu4, Chang Keun Lee5, Eun-So Lee1 
(1Department of Dermatology, Ajou University School of Medicine, Korea; 2Department of 
Dermatology, Yonsei University College of Medicine; 3Department of Dermatology, Gachon 
University of Medicine and Science; 4Department of Ophthalmology, Seoul National University 
College of Medicine; 5Department of Rheumatology, Asan Medical Center)
6. Morbidity of solid cancer in Behçet’s disease: Analysis of 11 cases in a series of 506 patients.
So Young Na, Jaeyoung Shin, Eun-So Lee 
(Department of Dermatology, Ajou University School of Medicine, Korea)
7.  Streptococcus sanguis and the sera of patients with Behçet’s disease stimulate membrane expression of 
alpha enolase in HDMECs.
Suhyun Cho, Zhenlong Zheng, Sung Bin Cho, Min Ju Choi, Kwang Hoon Lee, Dongsik Bang 
(Department of Dermatology and Cutaneous Biology Research Institute, Yonsei University College 
of Medicine, Seoul, Korea)
8. The role of CCL21 in HSV-induced Behçet’s disease-like symptoms.
Bunsoon Choi1, Hyun Chul Lim1, Ju A Shin1, Eun-So Lee2, Seonghyang Sohn1 
(1Laboratory of Cell Biology, and 2Department of Dermatology, Ajou University School of Medicine, 
Suwon, Korea)
9. Role of microRNA in the pathogenesis of Behçet’s disease.
So Young Na1, Mi-Jin Park1, Sun Park2, Eun-So Lee1 






10.  Clinical experience of interferon alfa-2a treatment in refractory uveitis of Korean patients with Behçet’s 
disease.
Ji-Youn Park1, Marvin Lee2, Ji Hun Song2, Ho Min Lew2, Eun-So Lee1 
(1Department of Dermatology, and 2Department of Ophthalmology, Ajou University School of 
Medicine, Suwon, Korea)
11. Surgical management of epiretinal membranes in Behçet uveitis.
Joo Young Shin1, Hyeong Gon Yu1,2, Tae Wan Kim1,3, Su Jeong Song4 
(1Department of Ophthalmology, Seoul National University College of Medicin; 2Sensory Organs Institute 
Medical Research Center, Seoul National University; 3Department of Ophthalmology, Seoul National 
University Boramae Medical Center, Seoul Metropolitan Government; 4Department of Ophthalmology, 
Sungkyunkwan University School of Medicine, Kangbuk Samsung Hospital, Seoul, Korea)
12. Renal manifestations in 2,007 Korean patients with Behçet’s disease.
Min Ju Choi1, Sung Bin Cho1, Jihyun Kim1, Shin-Wook Kang2, Tae-Hyun Yoo2, Zhenlong Zheng1, 
Hye Sun Lee3, Dongsik Bang1 
(1Department of Dermatology and Cutaneous Biology Research Institute, Yonsei University College 
of Medicine; 2Division of Nephrology, Department of Internal Medicine, BK21 Project for Medical 
Science, Yonsei University College of Medicine, and 3Department of Biostatistics, Yonsei University 
College of Medicine, Seoul, Korea) 
13. Associations between the HLA-A polymorphism and the ocular Behçet’s disease.
Chaerin Park1, Eun Ha Kang2, Yeong Wook Song3, Sujeong Kim1, Hyeong-Gon Yu1
(1Department of Ophthalmology, Seoul National University Hospital; 2Division of Rheumatology, 
Department of Internal Medicine, Seoul National University Bundang Hospital and 3Division of 
Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea)
14. Case reports on Behçet’s disease with new therapeutic approach derived from oriental medicine.
Jiyeon Yoon1, Nara Yoon1,2, Shinkyu Lee1, Youngjin Lee1 
(1Division of Autoimmune Disease, Nemizi Oriental Hospital, Korea and 2Institute for Regenerative 





Professors Seonghyang Sohn, Kyung Sook Park, Joo 
Young Rho, Eun-So Lee, Sungnack Lee, and Dongsik 
Bang at the 15th International Conference on Behçet’s 
Disease
Professor Dongsik Bang at the 15th International 
Conference on Behçet’s Disease in Yokohama, Japan
Professors Do Young Kim and Dongsik Bang at the 15th 
International Conference on Behçet’s Disease
Group photo at the 15th International Conference on 
Behçet’s Disease 






World Congress of Dermatology
At A Glance
WCD Date Place
18th 12-18 June, 1992 New York, USA
19th 15-21 June, 1997 Sydney, Australia
20th 1-5 July, 2002 Paris, France
21st 1-5 October, 2007 Buenos Aires, Argentina





18th World Congress of Dermatology
June 12-18, 1992
New York, USA
The Behçet’s Disease Workshop
Chairperson; 
Sungnack Lee (Korea) 
Co-chairpersons; 
Joseph L. Jorizzo (USA) , Türkan Saylan (Turkey)
1. Introduction
Sungnack Lee (Ajou University, Korea)
2. Etiopathology
Fumio Kaneko (Fukushima Medical College, Japan)
3. Immunological backgrounds
Joseph L. Jorizzo (Wake Forest University, USA)
Dermatologic Manifestations
1. Europe
Christos Zouboulis (Universitaetsklinikum Steglitz, Germany)
2. Middle East Asia
Türkan Saylan (University of Istanbul, Turkey)
3. East Asia
Dongsik Bang (Yonsei University, Korea)
Differential Diagnosis
1. Oral aphthae
Roy S. Rodgers, III (Mayo Clinic, USA)
2. Genital and extra-genital ulcerations






Amos Gilhar (Technion Israel Institute of Technology, Israel)
4. Sweet’s syndrome
Masako Mizoguchi (St. Marianna University, Japan)
Panel Discussion on Therapy 
Jean E. Revuz (Hôpital Henri Mondor, France)
Closing Remarks
Joseph L. Jorizzo (Wake Forest University, USA)
19th World Congress of Dermatology
June 15-20, 1997
Sydney, Australia
Session: Mucous Membrane Disease
Aphthous ulcers and Behçet’s disease
Dongsik Bang1, Eun-So Lee2, Mi Ran Whang2, Sungnack Lee2 
(1Yonsei University College of Medicine, Korea, 2Ajou University School of Medicine, Korea)
Professors Stephen I. Katz and Dongsik Bang at World 





20th World Congress of Dermatology
July 1-5, 2002
Paris, France
Symposium on Behçet’s Disease (S17)
Chairperson  Joseph L. Jorizzo (USA)
Co-chairpersons  Dongsik Bang (Korea) , Mehmet ali Gurer (Turkey) , Eric Esteve (France)
1. Overview
Joseph L. Jorizzo (USA)
2. Classification






Mehmet ali Gurer (Turkey) , Nilsel Ilter (Turkey)
6. Systemic lesions
Bertrand Wechsler (France), Eric Esteve (France)








21st World Congress of Dermatology 
September 30 - October 5, 2007
Buenos Aires, Argentina
Effects of vitamin D on expression of toll-like receptors in Behçet’s disease 
E-S Lee1, JE Do1, SY Kwon1, S Park2 
(1Department of Dermatology and 2Department of Microbiology, Ajou University, Suwon, Korea)
Professor Dongsik Bang at the 21st World Congress of 





22nd World Congress of Dermatology
May 24-29
Seoul, Korea




Mat M. Cem (Turkey) , Eun-So Lee (Korea), Fumio Kaneko (Japan)
1. Introduction
Dongsik Bang (Korea)
2. Historical background of Behçet’s disease 
Sungnack Lee (Korea)
3. Mucocutaneous manifestation of Behçet’s disease
Mat M. Cem (Turkey)
4.  The role of streptococcus in Behçet’s Diseases and the recent methods of self saliva for the diagnosis of 
Behçet’s diseases with aphtha
Koichiro Nakamura (Japan)
5. Candidate gene analysis
Hyeong Gon Yu (Korea)















1.  P0645 Immunohistochemical staining of IL-6, IL-17, IL-23, and TGF-β in cutaneous lesion of Behçet’s 
disease.
Kyu-yeop Lee, Eun-chun Han, Jihyun Kim, Sung Bin Cho, Dongsik Bang
2.  P1700 Erythema nodosum-like skin lesions associated with Behçet’s disease show 18F-fluorodeoxyglucose 
uptake on PET/CT.
Sung Bin Cho, Suhyun Cho, Jae-hoon Lee, Jong Doo Lee, Dongsik Bang
3. P1701 Detection of tuberculous lymphadenopathy by PET/CT in a patient with Behçet’s disease.
Suhyun Cho, Kyung Jong Lee, Jong Doo Lee, Dongsik Bang, Sung Bin Cho
4.  P1719 Vitamin D3 ameliorates herpes simplex virus induced Behçet’s disease-like inflammation in a 
mouse model through downregulation of toll-like receptors. 
Bunsoon Choi, Eun-So Lee, Seonghyang Sohn
Professors Dongsik Bang, Fumio Kaneko, Eun-So Lee, and Mat M. Cem at Symposium 







Edinburgh International Conference Center, Edinburgh, Scotland
Poster presentations
1. The role of M1/M2 macrophages in HSV-induced Behçet’s disease mouse model 
Seonghyang Sohn1,2, A.K.M. Mostafa Anower1, Ju A Shim1,2, Bunsoon Choi1, Hyuk Jae Kwon1, 
Dongsik Bang3 
(1Laboratory of Cell Biology, Institute for Medical Sciences, Ajou University, Suwon; 2Brain Korea 
Program, Ajou University, Suwon; 3Dept Dermatol, Yonsei University, Seoul, Republic of Korea)
2.  Serum IgA reactivity against GroEL of Streptococcus sanguinis and human hnRNP A2/B1 in patients 
with Behçet’s disease 
Sung Bin Cho1, Zhenlong Zheng1, Keun Jae Ahn2, Min Ju Choi1, Suhyun Cho1, Do Young Kim1,  
Hye Sun Lee3, Dongsik Bang1 
(1Department of Dermatology and Cutaneous Biology Research Institute, Yonsei University College of 
Medicine, Seoul; 2Specialization Research Center, Hallym University Hangang Sacred Heart Hospital, 
Seoul; 3Department of Biostatistics, Yonsei University College of Medicine, Seoul, Republic of Korea)





Su Rim Park1, Kyung Sook Park1, Young Joon Park2, Dongsik Bang3, Eun-So Lee2 
(1Biology, School of Biological Science and Chemistry, Sungshin Women’s University, Seoul; 
2Dermatology, Ajou University School of Medicine, Suwon; 3Dermatology, Yonsei University College 
of Medicine, Seoul, Republic of Korea)
4.  Epidemiological and clinical characteristics of Behçet’s disease in Korea-using a clinical database for 
patients’ registry 
So Young Na1, Do Young Kim2, Min Ju Choi2, Dongsik Bang2, Joo Young Roh3, Shin Seok Lee4, 
Eun-So Lee1 
(1Dermatology, Ajou University, Suwon; 2Dermatology, Yonsei University, Seoul; 3Dermatology, 
Gachon University Gil Medical Center, Incheon; 4Rheumatology, Chonnam National University, 
Kwangju, Republic of Korea)
Group photo of Professors Seonghyang Sohn, Joo Young Roh, Dongsik Bang, Sungnack Lee, and Eun-So Lee at the 





Congress of the European Academy of
Dermatology and Venereology
22nd Congress of the European Academy of Dermatology and Venereology
October 2-6, 2013
Istanbul Congress Center, Istanbul, Turkey
Behçet’s Disease (SY03)
Chair  Erkan Alpsoy (Antalya, Turkey)
Co-chairs: Dongsik Bang (Seoul, Korea)
  Christos Zouboulis (Dessau, Germany)
1. Epidemiology of Behçet’s disease
Meltem Önder (Leiner, Germany)
2. Specificity of papulopustular lesions in Behçet’s disease
Ayşe Boyvat (Ankara, Turkey)
3. Anti-endothelial cell antibodies in Behçet’s disease: Historical background
Dongsik Bang (Seoul, Korea)
4. Anti-endothelial cell antibodies in Behçet’s disease: Recent progress and unsolved questions
Do Young Kim (Seoul, Korea)
5. An algorithmic approach to the treatment of Behçet’s disease
Erkan Alpsoy (Antalya, Turkey)
6. An update on the diagnosis of the disease





Group photo of Professors Christos Zouboulis, Erkan Alpsoy, Dongsik Bang, Ayşe Boyvat, Meltem 
Önder and Do Young Kim at the Behçet’s Disease Symposium Session during the 22nd Congress of the 
European Academy of Dermatology and Venereology, Istanbul, Turkey in October 3, 2013
Professors Dongsik Bang and Do Young Kim at the Behçet’s Disease Symposium Session during the 





Introduction of Korea BehÇet Patron
Founded in October 1999, Korea Behçet Patron has made efforts to provide a variety of medical 
information for Behçet’s patients and their families and to ease the physical, psychological and economic 
pains that they suffer. Since the Korea Behçet Patron website (http://www.Behçet.co.kr) was opened in 
November 1999, it has served as a venue of actively exchanging information between the patients. In 
February 2000, the organization published the first issue of “Silk Road”, the newsletter of Korea Behçet 
Patron. Since then, it has published and distributed seasonal newsletter 2-4 times every year to keep 
providing useful information for Behçet’s patients. Together with Korean Society for Behçet’s Disease, Korea 
Behçet Patron jointly organizes ‘Seminar for Behçet’s patients and their families’ and regularly opens national 
or local meetings for Behçet’s patients. Internationally, on 19th – 22nd of May, 2000, the organization 
participated in ’The First International Convention for patients with Silk-Road Disease (Behçet’s disease)’ 
hosted by Professor Shigeaki Ohno, Japan. As such, Korea Behçet Patron continues to have a variety of 
domestic and international exchanges.
Korea Behçet Patron actively joins the activity to establish a national policy on rare and incurable 
diseases by constantly giving opinions to relevant national projects on behalf of patients. In addition, the 
organization helps isolated patients to receive social welfare benefits and is doing public relations work to 
improve the public perception of Behçet’s disease. Also, Korea Behçet Patron holds a one-night and two-day 
event through which old Behçet’s patients encourage young patients to overcome their difficulties and give 
hopeful messages to them. The organization supports Behçet’s patients who have become blinded by severe 
development of the disease, to live together in nursing facilities for the disabled like ‘House of Rudia’, to rely 





“The Silk Road” Newsletters of Korea Behçet Patron
As such, Korea Behçet Patron devotes itself to providing medical and economic support for Behçet’s 
patients and improving their emotional health. Together with medical personnel, Korea Behçet Patron will 





Special contributions of KSBD scientists 
The Korean Study Group for Behçet’s Disease, formerly the Korean Society for Behçet’s Disease (KSBD), 
was organized in 1999, with Prof. Sungnack Lee appointed as its the First President. Since its establishment, 
the society has held annual meetings, and its members have participated enthusiastically in various academic 
activities. Numerous academic achievements were made by the KSBD scientists, and many of them gained 
world recognition. Representative accomplishments can be classified into basic research and clinical studies.
First, in 1996, in the field of basic research, herpes simplex virus (HSV) DNA was revealed in the saliva 
of Behçet’s disease (BD) patients by the polymerase chain reaction.1 In 1998, an animal model of BD was 
developed by inoculation of HSV type 1 into ICR mice.2 These animal models allowed more effective 
investigations, including establishment of several therapeutic models,3,4 in the field of BD. In studying the 
etiology of BD, α-enolase was identified as a target antigen of IgM-type anti-endothelial cell antibody (AECA) 
in patients with BD,5 and in 2012, hnRNP A2/B1 was identified as a target antigen of IgA-type AECA in BD.6 
The exact pathogenic role of AECA in BD remains to be fully elucidated, but identification of AECA can 
be interpreted as an epiphenomenon reflecting epithelial or endothelial cell damage secondary to chronic 
inflammation, or an autoimmune response AECA as a pathogenic factor inducing inflammation. The role 
of vitamin D was also investigated, and this vitamin was revealed to modulate Toll-like Receptor (TLR)2 
and TLR4 expression of monocytes in BD; these are known to be important mediators in the inflammatory 
reaction.7 In 2011, vitamin D3 was also reported to ameliorate HSV-induced BD-like inflammation in a 
mouse model through down-regulation of TLRs.8 In addition, a meticulous flow cytometric analysis of the 






Genetic studies in BD patients identified the presence of the HLA-G 3741_3754ins14 variant; a lower 
mRNA level is probably associated with the development of BD.10 Several genome-wide association 
studies were also conducted by KSBD members, who discovered that BD patients have polymorphisms in 
endothelial nitric oxide synthase,11 IL-6,12 matrix metalloproteinase (MMP)-2, -9, -12, and tissue inhibitor 
of MMP-2 genes,13 and that interactions between IL-17A, IL-23R, and STAT4 polymorphisms confer 
susceptibility to intestinal BD in the Korean population.14 
Clinical investigations were also performed by the KSBD members. Even before the society took form 
as an organization, a poster entitled “Clinical Spectrum of Behçet’s Disease” was presented by Professor 
Dongsik Bang, along with other doctors studying BD, at the 50th Annual Meeting of American Academy 
of Dermatology in 1991, and was recognized with the Gold Award for Teaching Value. In 1994, a clinical 
analysis was performed on 40 cases of childhood-onset BD,15 and in 1997, the influence of pregnancy was 
studied on the course of BD in 27 pregnant women.16 The first multicenter study in BD from 20 hospitals 
was conducted in 2001 for an epidemiologic and clinical survey.17 In 2001, KSBD scientists published a 
photo-monograph of Behçet’s Disease: A guide to its clinical understanding; with 147 figures and 121 
tables, which clarified the various clinical features of BD, especially dermatologic features.18 In 2003, the 
influence of sex on BD in Korea was studied in 1,901 enrolled BD patients,19 and the first Mongolian case 
of BD showing HLA B51, MICA gene type *5/*6 was reported in the literature by KSBD members.20 In 
2009, a novel diagnostic criterion for intestinal BD was developed by the IBD Study Group of the Korean 
Association of the Study of Intestinal Diseases, and received worldwide attention.21 This group also found 
meaningful biological markers, such as soluble triggering receptor expressed on myeloid cells-1 (sTREM-1), 
that correlated with disease activity.22
In addition, KSBD members joined in international cooperation studies including the Behçet’s disease 
activity index23 and genome-wide association studies24,25.
The Behçet’s Disease Specialty Clnic at Severance Hospital, Yonsei University College of Medicine and 
Ajou University Hospital published the first and second editions of the Reference Index on Behçet’s disease 
and distributed these to researchers and institutions around the world to provide invaluable assistance to all 
the dedicated researchers of Behçet’s disease. A total of 4591 papers were put together to make up the second 
edition. 





mention one by one, but they cover various fields including basic research, dermatology, gastroenterology, 
ophthalmology, rheumatology and so on. KSBD has maintained its reputation due to the great efforts and 
contributions of its members. The KSBD members remain keen, which bodes well for a promising future.
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Samir Helmy Assaad-Khalil, M.D., Ph.D
Professor of Internal Medicine
Former Head of the Department of Internal Medicine
Alexandria Faculty of Medicine
Alexandria University, Alexandria, Egypt
Former Treasurer of ISBD
Former Chairman of the Clinical Reasearch Study Group of the ISBD
It is a great pleasure and honour for me to send my sincerest and cordial congratulations to the Korean 
Society for Behçet’s Disease, and to my dear friend Prof. Dongsik Bang, MD, PhD, President of the Society 
for the 30th Anniversary of Behçet’s Disease Specialty Clinic which mirrors the bright history of Behçet’s 
Disease in Korea. I send also my greetings and congratulations for the retirement of Prof. Dongsik Bang 
wishing him all health to pursuite his honorable carrier in the service of Behçet’s Disease patients, colleagues 
in the medical community, academic scientific work and international activities.
In the context of the patients’ service, a landmark in the history of Behçet’s Disease in Korea, even in the 
whole world has been the opening of the Behçet’s Disease Specialty Clinic in Severance Hospital of Yonsei 
University College of Medicine on November 10th, 1983, which was the first such clinic in Korea. Although 
Prof. Dongsik Bang is a dermatologist, he has contributed his whole life in his university to the clinical care 
of patients with Behçet’s disease and scientific research for this rare recalcitrant disease and until now.
In the field of serving the medical community, Prof. Dongsik Bang has gathered all publications related to 
Behçet’s Disease in valuable volumes and disseminated them to all his colleagues in Korea and all over the 
world. His relentless activities in the Korean Society for Behçet’s Disease, International Society for Behçet’s 
disease, the World Congress of Dermatology, the International Congress of Behçet’s Disease in Korea then 
in Japan reflect his commitment to serve patients, colleagues and research.
In the domain of Academic Scientific Research, besides the above mentioned activities, he worked in 
the fields of epidemiologic studies, animal model, role of HSV in the pathogenesis in Behçet’s disease, anti-





enolase, HnRNP-A2/B1 which have been reported. His research activies encompassed both basic science 
research and translational research for the benefit of patients.
In the arena of international activities, Prof. Dongsik Bang has an unforgettable impact on the 
International Society of Behçet’s Disease, he could gather all members for the sake of the society and the 
welfare of patients. During is presidency, besides maintaining and strenghtning frienship between all 
members of the society, he fostered important scientific activities. Among many, the neuro-Behçet’s Group 
has been formed and evolved important activities, the pediatic group published important data. Moreover 
and for the first time in the research history of Behçet’s Disease more than 50 members gathered in a huge 
multi nation team work in the domain of the clinical diagnosis of the disease. 
It is difficult for me to cover all activities and achivements of Prof. Dongsik Bang, I may need the whole 
book for that. Even more difficult to is find the proper words to describe my deep appreciation and pride 
of having known Prof. Dongsik Bang as a humanistic personality. I have known Prof. Dongsik Bang as a 
human being respecting all, caring for all and serving everybody. Caring for patients welfare, cooperating 
with his colleagues and students, genuine researcher, arts protector, but above all, a sincere friend. No words 
can express my deep appreciation for this deep frienship. 
I wish the best for Prof. Dongsik Bang, to continue to serve, patients, colleagues, academia and humanity. 
I wish the best for the Korean Society for Behçet’s Disease for the Behçet’s Disease Specialty Clinic and for all 







Chief, Department of Rheumatology, 
Marmara University, School of Medicine,
Pendik, Istanbul, Turkey
Dear Dr. Bang,
I am very pleased to hear the 30th anniversary of the Behçet’s Disease (BD) Speciality Clinic in Severance 
Hospital of Yonsei University College of Medicine. This is an important event for the advancement of 
Behçet’s Disease, both in Korea and the worldwide Behçet’s community. 
BD Specialty Clinic is one of the few dedicated Centers in the world, with uninterrupted devotion to 
patient care, education and research in BD. Starting with the efforts of Prof. Sungnack Lee and Prof. Dongsik 
Bang, the Clinic, over many years, continued the management of thousands of BD patients in Korea with 
excellent care. The Clinic also educated the physicians from many different medical disciplines interested in 
BD, both from Korea and other countries and published important clinical and basic studies. 
BD Speciality Clinic pioneered some important collaboration worldwide on BD education and research. 
One of the important events was the collaborative “Turkey-Korea Behçet’s Days”, which were done 
consecutively in two countries. In fact, these Meetings were the first occasions that I met with my Korean 
colleagues, which further led to most valuable collaborations and great friendships. Later on, I also had 
several chances to visit Korea and met with the Korean colleagues in International Meetings, such as the 
9th International Conference on Behçet’s Disease in 2000, in Seoul. This Meeting enabled many Turkish 
physicians to experience the hospitality of our Korean colleagues, in addition to the very high standards of 
scientific content. The historical ties between Korea and Turkey are deeply rooted in both countries and we 
had a great chance to feel and share this in Seoul that year.  





immunopathogenesis, clinical features and the treatment of Behçet’s Disease. The Clinic’s early studies 
concentrated on understanding the immunopathogenesis of erythema-nodosum like lesions in BD. 
Later on their studies on human dermal microvascular endothelial cells, anti-endothelial antibodies 
and their possible streptoccocal etiology led us to understand better the mechanisms behind cutaneous 
and microvascular damage in BD. Herpes Simplex induced ICR mouse model, which is developed in 
collaboration with Prof. S. Sohn from Ajou University, gave us important clues about the mechanisms of 
disease process and enabled the study of various therapeutic agents. At the same time, the Clinic’s research 
on the epidemiology, clinical features and outcome of BD in Korea helped us in clarifying the clinical nature 
of BD.
BD Specialty Clinic also had important contributions to International Society for Behçet’s Disease (ISBD). 
Prof. S. Lee and Prof. D. Bang led the Society as the President and Secretary between 2008-2012. They had 
very important contributions to the progress of the Society and I felt very proud and honored to work with 
as them as a member of Executive Committee during these years. 
With this occasion, I learned the retirement plans of Prof. Dongsik Bang in two years time. Both as a 
colleague and a friend, I had great moments with him, shared many memories and would like to wish him 





Kenneth T. Calamia, M.D. and J. Desmond O’Duffy, M.D.
Kenneth T. Calamia, M.D.
Mayo Clinic
Jacksonville, FL, USA
J. Desmond O’Duffy, M.D. 
Honorary Life President of International Society of Behçet’s disease
Intercostal Rheumatology 
Sarasota, FL, USA
It is with great pleasure and deep respect that we extend our congratulations on the anniversary of the first 
Behçet’s Disease Specialty Clinic in Korea.  
For 30 years since its opening at Severance Hospital of Yonsei University College of Medicine, the clinic 
has been a leader in clinical and research activity, advanced the science and the care for Behçet patients. 
Output from the clinic has included the training of new Behçet’s experts. Not only has the clinic benefited 
patients from Korea and East Asia, but the knowledge gained has had a global impact on providers and 
sufferers. 
In 2000, members of the International Society on Behçet’s disease were welcomed to Korea for the 9th 
International Conference and were able to come away with a better understanding of the significance of the 
clinic. Prior to that, collections of articles were published by the distinguished group of Dongsik Bang, Eun-
So Lee, Seonghyang Sohn and Sungnack Lee reflecting their experience in the care of several thousands of 
patients. The work of the group continues to the present time. The International Society on Behçet’s Disease 
was under the leadership of its third president, Sungnack Lee, from 2008 to 2012.
The publication of Behçet’s Disease in Korea also marks the beginning of the transition of Dongsik Bang 
into retirement. Dr. Bang has served as the Vice Director of Severance Hospital, President of the Korean 
Society for Behçet’s Disease and is Professor in the Department of Dermatology, Yonsei University College 
of Medicine.  





Behçet’s Disease in Korea chronicles the history of Behçet’s disease in that country and includes the 
domestic and international academic activities led by their group. With the retirement of Sungnack Lee as 
Professor before him, succession planning gives us the confidence that the wonderful work of the Behçet’s 





Ahmet Gül, M.D. 
Professor of Medicine
Istanbul University, Istanbul, Turkey
A Dedicated Center of Excellence for Behçet’s Disease Research
Secretary General of International Society for Behçet’s Disease
Behçet’s disease, a rare inflammatory disease of complex etiology, has a peculiar geographic distribution 
with an increased prevalence along the ancient Silk Road, spanning from the Eastern Mediterranean 
countries to Korea, Japan, and China. Despite the epidemiologic difficulties, its clinical and inflammatory 
characteristics attracted the attention of several physicians and scientists from different disciplines. 
Professor Hûlusi Behçet, who described the disease as a separate entity, was a dermatologist. However, its 
truly systemic nature has made a multi-disciplinary approach necessary, with involvement of an enlarging 
family of specialties including ophthalmology, internal medicine, rheumatology, immunology, neurology, 
vascular surgery, pathology, epidemiology, microbiology, genetics, and so on. I believe that the greatest joy of 
studying Behçet’s disease is working within a close family of devoted students of the disease from all over the 
world. They have different backgrounds and trainings but all are very happy to contribute to the same goal of 
understanding and solving its mysteries for the sake of patients with Behçet’s disease.
In rare disorders like Behçet’s disease, establishment of dedicated centers seem to be the only solution for 
accumulation of critical amount of data for making important progress in the identification of underlying 
causes and development of appropriate treatments. One of the best examples of such centers and the first in 
Korea, The Behçet’s Disease Specialty Clinic in Severance Hospital of Yonsei University College of Medicine, 
celebrates its 30th anniversary of the opening this year. We all cordially congratulate our Korean colleagues, 
who established this center and have made such an excellent contribution to the Behçet’s disease so far. The 
state-of-the art research conducted at the Behçet’s Disease Specialty Clinic has covered the whole clinical 
spectrum of the disease and its basic aspects with investigations on the immunology and genetics of Behçet’s 





Professor Dongsik Bang, the current head of the Specialty Clinic, is an eminent student of Behçet’s 
disease, and he has played a fundamental role by attracting several young researchers into the field and kept 
Behçet’s disease research vibrant and influential in Korea. Professor Bang will also be long remembered for 
his excellent job as the Secretary General of the International Society for Behçet’s Disease along with the 
presidency of Professor Sungnack Lee.
Professor Bang has always been a very sincere and modest colleague and friend. He will be retired in two 
years, but I believe that his work will continue to guide and contribute to the education of Behçet’s disease 
students all around the world. I also hope that he will remain fruitful in this period of his life and have an 
opportunity to spend more time with his family and his other interests.
Congratulations again on the achievements and 30th anniversary of Behçet’s Disease Specialty Clinic and 





Vedat Hamuryudan, M.D. 
Department of Internal Medicine, Division of Rheumatology, 
Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey 
I would like to express my sincere thanks to Prof. Dongsik Bang, the President of the Korean Society 
for Behçet’s Disease, for giving me the honor to celebrate the 30th year anniversary of the Behçet’s Disease 
Specialty Clinic in Severance Hospital of Yonsei University.
Whether you call it a syndrome or a disease, the enigmatic features of this disorder continue to attract 
scientists and physicians from virtually every field of medicine. The multi-systemic nature of Behçet’s disease 
and its unpredictable course mandates close collaboration between different disciplines. Accordingly, 
specialty clinics play the key role for the progress of our understanding of various aspects of Behçet’s disease. 
Prof. Bang and his colleagues must be congratulated for being among the few pioneers in establishing such 
a specialty clinic and for maintaining it for such a long time. The group’s numerous contributions to the 
literature in prestigious journals are another reflection of the success of this specialty clinic.
Until I started to study rheumatology, Korea was for me a friend and sister country as taught during my 
high school education. I had learned that Turkey and Korea were allies, that there was a Korean Garden 
with a monument in Ankara and also a cemetery of Turkish soldiers in Busan. In 1991, I realized that 
our friendship and relation with Korea goes far beyond what I had learned before. At that time, having 
completed my initial clinical studies in Behçet’s disease, I had the opportunity to attend the first Korea-
Turkey Joint Meeting of Behçet’s Disease in Istanbul. This was the beginning of my long-lasting friendship 
with Korean experts in Behçet’s disease, like Prof. Dongsik Bang, Prof. Sungnack Lee and Prof. Eun-So Lee, 
to be named at first. The Korea-Turkish joint meetings continued to be organized every 2 years alternating 





results as well as for consolidating our friendship. Although these successful meetings could not continue 
because of economic reasons, our close relationship with the Korean colleagues continued without any 
interruption at various international conferences. It should also be underlined that an important milestone 
in the history of Behçet’s disease, the foundation of the International Society for Behçet’s Disease (ISBD), 
occurred at the International Conference in Seoul in 2000. 
Although there has been much advance in our understanding and management of Behçet’s disease many 
unmet needs still remain. Close co-operation between disciplines and between physicians from different 
countries is of utmost importance in achieving progress and on behalf of Prof. Dongsik Bang I thank our 





Dorian O. Haskard, DM FRCP FMedSci
Head of Vascular Sciences, National Heart and Lung Institute
Head of Immunology and Inflammation, Department of Medicine
Imperial College, London, UK
Dear Professor Dongsik Bang,
It is a great pleasure to write to you on the occasion of 30th anniversary of the Behçet’s Disease Specialty 
Clinic at Severance Hospital of Yonsei University College of Medicine, and upon the occasion of your 
retirement.
I should like to congratulate you sincerely on your many achievements during a most distinguished 
career. Specifically, you have become a world expert on Behçet’s Disease. You have made very substantial 
contributions to the development of understanding of this rare but important condition through care of 
patients, through your many excellent publications, and through your participation in the International 
Society for Behçet’s Disease (ISBD). The ISBD greatly benefited from your wisdom and hard work during 
your tenure as Secretary of the Society, and it was a pleasure working with you in my capacity as Treasurer.
I trust that the Behçet’s Disease Specialty Clinic at Severance Hospital will go from strength to strength 
both in clinical care and research on the back of the firm foundations you have established. I also wish you 






Yoshiaki Ishigatsubo, M.D., Ph.D.
Internal Medicine and Clinical Immunology
Yokohama City University 
Yokohama, Japan
Dear Professor Bang,
First of all, I would like to extend to you my heartfelt congratulations for the 30th anniversary of the 
opening of the Behçet’s Disease Specialty Clinic.
According to your information, the Behçet’s Disease Specialty Clinic was opened in Severance Hospital of 
the Yonsei University College of Medicine on November 10th, 1983 and it was the first specific clinic of its 
kind in Korea.
 I believe what you have done until now has had a tremendous influence in clinical progress in the medical 
treatment of Behçet’s disease in Korea as well as providing new insight into the role of research in Behçet’s 
disease on a global level. I have worked with you in the field of Behçet’s disease for several years. Now, I am 
very proud of and also respect you very much as one of my best friends.
On the occasion of my holding of the International Behçet’s Disease meeting in Yokohama in July 2012, 
your cooperation and suggestions led to a successful meeting. Therefore, I thank you for your kindness 
beyond all description personally. In addition, I have to refer to your support for Japan-Korea joint meeting. 
We held the Japan-Korea joint meeting on Behçet’s disease three times from 2007 in Yokohama and Seoul . I 
believe the meeting brought us, not only scientific knowledge, but also friendly relations. When the meeting 
was held in Seoul, I was deeply touched by your courtesy between the two countries. You and Professor 
Lee brought me to several special places and you also guided your hospital. In this way, I owe you a debt of 
gratitude and am impressed, directly and indirectly, to be a good partner. 
My spirit is dampened upon hearing you will retire in another two years. Although the Behçet’s Disease 





become competent professionals under your watch, you are irreplaceable. 
I believe all of our colleagues in the Behçet’s society all over the world admire your contribution to the 







Fumio Kaneko, M.D., Ph.D.
Emeritus Professor of Fukushima Medical University,
Director, Institute of Dermato-Immunology and Allergy, 
Southern TOHOKU Research Institute for Neuroscience, 
Koriyama, Fukushima, Japan
It is a great honor for me to write the address in your publishing “Behçet’s Disease in Korea” as the 30th 
anniversary of the opening of Behçet’s Disease Specialty Clinic. I deeply appreciate that you have been 
researching on the pathogenesis of Behçet’s disease (BD) and that you have been working to treat BD 
patients for long time with Professor Sungnack Lee, the former President of Gachon University of Medicine 
and Science, in Korea. It is very happy for me that I was quite often invited to the meetings in your country 
and that I could make a lot of wonderful Korean friends thanks to you. On the contrary, I truthfully felt that 
you sometimes were a competitor to me and also that you were a cooperator with me in BD investigations. 
Your worldwide contributions made us a big impression. 
Let me recall that it was 1984 when I firstly visited and gave a lecture on “Immune phenomena of Behçet’s 
disease” in kind invitation by Professor Sungnack Lee in Yonsei University. Then, it was very surprised for 
me to find that you had already treated a number of BD patients gathered from the local areas in your clinic. 
Since then, we have studied BD pathogenesis in the aspects of microorganism immunity including oral 
streptococci and herpes virus which we have each other discussed a lot in the World Congress.
In 2012, we had the 15th International Conference on Behçet’s Disease in Yokohama, Japan, which was 
greatly successful, thanks to your big affectionate contributions. Now, we are also going to newly publish 
“Immune reactions in Behçet’s disease” in the special issue of the Journal, Genetics Research International by 
Hindawi Publishing Corporation, as you and I are the Editors.  





Isabelle Koné-Paut, M.D.                               
Department of Pediatrics and Pediatric Rheumatology, 
University of Paris SUD, Bicêtre Hospital, Paris, France
Behçet’s disease is a condition of high frequency in Korea and other far Eastern countries. The Yonsei 
university of Korea has become a well-known center of care and research on Behçet’s disease and has cre-
ated the first dedicated clinic to Behçet’s disease in Korea at the Severance hospital in November 1983, just 
30 years ago. The same university has chaired the 9th International Conference on Behçet’s Disease, Seoul, 
in May 2000, where the International Society for Behçet’s Disease (ISBD) (derived from the activities of the 
International Study Group for Behçet’s Disease formed in 1977) was established. Several physicians from 
this famous institution have become great “names” in the field of Behçet’s disease. One of them, Professor 
Dongsik Bang who is retiring in the next 2 years, has provided an exceptional contribution to both the 
clinical and the fundamental aspects of Behçet’s disease. Professor Dongsik Bang has graduated his medical 
education at the Yonsei University College of Medicine, where he has obtained his final graduation in 1985. 
He has occupied a full position as MD.PhD in the department of Dermatology and Cutaneous Biology 
Research Institute, Seoul, Korea. He has lead a first multicenter, retrospective survey on epidemiologic and 
clinical features of the patients with Behçet’s disease around the nation from 1997 to 1999, which identified 
3,497 patients in whom 1,527 were classified into complete or incomplete type of Behçet’s disease according 
to the Shimizu’s classification. J Korean Med Sci 2001; 16: 615-8. Prof. D Bang has published 85 papers on 
Behçet’s disease in international journals (Pubmed) in the domain of mucocutaneous aspects, endothelial 
cells dysfunction and activation in vasculitis, and neutrophils activation. He has given multiple lectures in 
international meetings and published a high-quality educational book on Behçet’s disease: “Behçet’s Disease: 
A Guide to Its Clinical Understanding Textbook and Atlas” in collaboration with Profs. Sungnack Lee and 





societies. He has been the General Secretary of International Society for Behçet’s disease, since 2008, the 
President of the Korean Society for Behçet’s Disease, since 2007 and of the President of the Korean Society 
for Investigative Dermatology since 2011. He has been member of the editorial board of several journals like 
Annals of Dermatology and Clinical Experimental Rheumatology. 
The 30th anniversary of the Behçet’s disease clinic is a great opportunity to congratulate all the physicians 
collaborating in this exceptional educational, care and research structure. I express my compliments to Prof. 
D Bang for his historic book on Behçet’s disease in Korea, and my best wishes for his approaching retire-
ment. I am very honoured to address this congratulatory message and to be invited in Seoul to celebrate a 










Istanbul University, Istanbul, Turkey
20 years friendship with Dongsik Bang
Our relationship with Korean Behçetologists began in 1991, with their visit to Department of 
Dermatology of Istanbul University where Prof.Dr. Hûlusi Behçet had worked, who first described Behçet’s 
disease and to Prof.Dr. Türkan Saylan. During this visit, Professor Sungnack Lee, Professor Dongsik Bang 
and Professor Türkan Saylan have settled on a biannual organisation of Turkey Korea Joint meeting on 
Behçet Disease and first meeting was done in Istanbul University, Department of Dermatology. Prof.Dr. 
Türkan Saylan invited me to participate The second Korea Turkey joint meeting on Behçet’s disease in 1993, 
in Seoul.  Prof.Dr. Türkan Saylan, Guzin Özarmağan and I were the participants of this meeting from Turkey. 
It was our first chance of exchange of knowledge and experience with Korean colleagues. In 1995 third 
meeting was held in Istanbul, at İstanbul University Doctorate Hall. This meeting was also the last meeting 
which Prof.Dr. Türkan Saylan could participate. Dongsik Bang, Sungnack Lee, Eun-So Lee, Seonghyang 
Sohn from Korea and Fumio Kaneko from Japan joined this meeting and opening speech was done by 
rector Bülent Berkarda. In this meeting our colleagues from Cerrahpasa Behçet’s disease clinic had a chance 
to meet with Korean colleagues. In 1997, we also took part in The Fourth Turkey Korea Joint Meeting on 
Behçet’s disease in Kyongju, together with Prof.Dr. Sebahattin Yurdakul, Prof.Dr. Vedat Hamuryudan and 
Prof.Dr. Aysel Gürler from Ankara. During our visit to Seoul, we also visited Yonsei University Behçet’s 
Disease Speciality clinics and we were able to observe animal models of experimental Behçet’s disease. Last 
Turkey Korea Joint Meeting on Behçet’s Disease was organised at Ankara University Medical Faculty and 





disaster in Turkey, in 1999.  
The article about the life of Hûlusi Behçet, published by Prof.Dr. Türkan Saylan in Yonsei Medical Journal 
is a very valuable source on this topic and has been cited many times in the literature. Also another article 
by Prof.Dr. Aysel Gürler was published in the same journal, about case series of Behçet’s disease in Ankara 
University. Dr. Bang and I took part in many studies together. Last one was a chapter titled “Mucocutaneous 
findings of Behçet’s disease and pathergy phenomenon” in the book “Behçet Syndrome”, edited by H. 
Yazıcı and Y. Yazıcı. Dr. Bang and other Korean colleagues declared their opinions in various articles and 
conferences about the naming of the disease described by Hûlusi Behçet and they emphasized that the term 
“Behçet’s Disease” should be used in the literature instead of other synonyms. 
Dr. Dongsik Bang participated in the organization of many Behçet’s Disease conferences and congresses, 
one of them was the 9th International Conference on Behçet’s Disease, Seoul, May 2000. He was also 
involved in the organisation of 22nd World Congress of Dermatology 2011 Seoul.  He has also many 
contributions to the literature on Behçet’s Disease.
I wish a healthy and happy retirement and an everlasting friendship with Dr Bang, whose scientific 






Associate Professor at Innsbruck Medical University, Innsbruck, Austria  
Treasurer of the International Society of Behçet’s Disease 
Dear Prof. Dongsik Bang,
First I want to note that it is a true honor and real pleasure for me to write a congratulatory message for 30 
years of Behçet’s Clinic in Korea. This is a really nice event, and I am sure that this book will present a lot of 
activities for care and research on Behçet’s disease in Korea over this long period of time.
In November 1983 the first Korean specialty clinic for patients with Behçet’s disease opened the doors at 
Yonsei University College of Medicine. Driven by the dermatologist Prof. Dongsik Bang, current president 
of the Korean Society for Behçet’s Disease, this clinic became an ongoing success: Only 2 years and 4 months 
later, in march 1986, this clinic already followed more than 400 patients with this systemic vasculitic disease 
usually classified as a “rare” disease (Kim HJ, Bang D, Lee SH, et al. Yonsei Med J. 1988). Obviously there 
was the urgent need for such a clinic in Korea, and Yonsei University since then served the population by a 
specialty clinic in this important field. 
Prof. Bang has continued this important work until today. One could conclude that he contributed his 
whole life in his university to the clinical care of patients with Behçet’s disease and scientific research for this 
rare recalcitrant disease. However, he also served successfully the International Society of Behçet’s Disease as 
a secretary over several years and still supports not only national but also international academic projects in 
his field.
Indeed, Prof. Bang showed us that excellent clinical work can stimulate interesting research projects. 
Over the years he published numerous interesting and important new clinical aspects on Behçet’s disease 
especially in Korean patients. At the same time he expanded his list publications on pathophysiological 





erythema nodosum-like lesions of Behçet’s patients (Bang D, et al. J Toxicol Sci. 1987). Since then numerous 
publications followed, including reports on an animal model of Behçet-like disease, which not only 
explained the role of HSV and other pathophysiological mechanisms in Behçet’s disease but also allowed 
the development of new interventional approaches. Besides, he reported on antiendothelial cell antibodies 
in Behçet’s disease with the detection of new possible target antigens including α enolase. Overall the list of 
Korean publications since then is long and more aspects will be presented in this book.
This book will summarize the Korean history of care and research in Behçet’s disease. For this reason I 
want to congratulate Prof. Bang and the whole team of coworkers of the specialty clinic for patients with 
Behçet’s disease at Yosei University College of Medicine, and I hope that this clinic will continue its work for 
the sake of the Korean Behçet patients. Patients need a competent address for their problems, supporting 
and coordinating the variety of disciplines involved in this systemic disease. 
Therefore I wish all the best to Prof. Bang as the initiator of this activity with the specialty clinic for patients 
with Behçet’s disease at Yosei University College of Medicine and all colleagues supporting the Korean 







Graham Wallace, M.D.                                    
Academic Unit of Ophthalmology
School of Immunity and Infection
College of Medical and Dental Sciences
University of Birmingham, Birmingham, UK
Professor Dongsik Bang has been at the forefront of research into Behçet’s disease (BD) for the last 25 
years. As a dermatologist he has brought a unique insight into this complex disease by analysing responses 
in cutaneous tissue of patients and in particular the pathognomonic features that separate from other 
conditions. His output has covered the gamut of inflammatory and immune response. In his long-term 
collaboration with Professor Sungnack Lee, Professor Bang was involved in first documenting the extent of 
BD in Korea, and analysing the HLA associations with disease in Korean patients. The results showed that 
HLA-B51 was strongly associated with disease in this patient cohort as had been identified in other ethnic 
groups. These findings in the early days of genetic research into BD directed research into the understanding 
of this strong association, work that continues to this day, on genome-wide association studies that identified 
loci of interest across the geographical range of BD.
His work on the lesion types in skin and the hyper-response to challenge (pathergy) have been a constant 
feature of Professor Bang’s contribution to BD research. This information together with in depth analysis of 
antibodies in serum of patients including anti-endothelial, anti-enolase and anti-cyclic citrullinated peptide 
(CCP) have been used to improve early diagnosis of BD which is a constant problem for patients. For 
example anti-CCP antibodies are an important marker for rheumatoid arthritis, another disease with joint 
involvement, were shown to have very low prevalence in patients with BD. 
In an another collaboration with Dr Seonghyang Sohn, Professor Bang has published widely on an 
animal model of BD. Injection of herpes virus into mice elicits lesion in the eyes, skin, joints and GI 
tract. Interestingly, not all mice develop the same or any symptoms allowing for a detailed analysis of the 





intervention including the use of T regulatory cells, thalidomide and small-interfering RNA against tumour 
necrosis factor in controlling disease.
The research output of Professor Dongsik Bang shows both his forward thinking and strong collaborative 
nature. The latter was particularly necessary when he was elected Secretary of the International Behçet’s 
Disease Society. His calm demeanour, and natural charm, allied to his organised and collegiate approach 
made him and excellent choice and he was extremely successful in the post. Finally, since my own entry 
into the field of Behçet’s disease I have admired Professor Bang’s work and as importantly come to call him a 
friend as well as a colleague, whose company and insight at meetings are always to be welcomed. I wish him 









Current position Professor, M.D., Ph.D.
Organization Department of Dermatology, Yonsei University College of Medicine
Address 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea




1976  Bachelor of Medicine, Yonsei University College of Medicine 
1982  Dermatology, Master of Medicine, Graduate School of Yonsei University 
1985  Dermatology, Ph.D., Graduate School of Yonsei University
▪ Post-graduate training
1979 - 1980  Internship, Severance Hospital, Yonsei Medical Center





1985 - 1986   Visiting Fellow, Department of Dermatology, Kawasaki Medical School, Juntendo 
University School of Medicine, Japan 
▪ Teaching appointment & Experiences 
1984 - 1987  Instructor, Department of Dermatology, Yonsei University College of Medicine 
1987 - 1990   Assistant professor, Chairman, Department of Dermatology, Yonsei University Wonju 
College of Medicine 
1990 - 1993  Assistant professor, Department of Dermatology, Yonsei University College of Medicine 
1993 - 1998  Associate professor, Department of Dermatology, Yonsei University College of Medicine 
1995 - 1996   Secretary of the Preparatory Committee of 1st Self-assessment of Yonsei university 
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1998 - present  Professor, Department of Dermatology, Yonsei University College of Medicine
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2005 - 2007  Director of Severance Quality Improvement Department
2007 - 2010  Vice Director, Severance Hospital, Yonsei University College of Medicine
▪ Society
1997 - 1999   Chairman of Board of Director, Korean Society for Investigative Dermatology 
1999 - 2001   Executive member (Scientific Affairs) of Board of Director, Korean Dermatological 
Association 
1999 - 2007  Secretary General, Korean Study Group for Behçet’s Disease






2000 - 2004  Board of Council, International Society for Behçet’s disease
2001 - 2011  Member of Board of Director, Korean Dermatological Association
2002 - present   Editorial Board of Clinical Experimental Rheumatology: Behçet’s disease and other 
autoinflammatory conditions
2004 - 2012   Executive member (Secretary General) of Board of Council, International Society for 
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2007 - 2012  Editor in Chief of Korean Dermatological Association 
2007 - present  President, The Korean Society for Behçet’s Disease
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Behçet’s disease
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The Editor’s Comments and Acknowledgement
The plan for a book titled “Behçet’s Disease in Korea” was discussed at the end of March 2013. It was 
necessary to collect international and domestic scientific activities such as papers, photos, and many 
meetings. Although only 52 years have passed since the first report of a patient with Behçet’s disease in Korea, 
the number of related scientific activities has been beyond expectation. This year has a special meaning: The 
Behçet’s Disease Specialty Clinic at Severance Hospital of Yonsei University College of Medicine, which was 
the first of its kind in Korea, will honor the 30th anniversary of its opening. It was also necessary to review 
the history of the Korean Society for Behçet’s Disease from 1999 to 2013. At the end of the book, Professor 
Dongsik Bang’s curriculum vitae and papers related to Behçet’s disease were added.  It was impossible 
to compile all achievements and academic activities Korean investigators have made into a single book. 
Especially, we would like to ask for understanding that topics which were presented in international or 
domestic meetings of academic divisions were not included in this book because of space limitations. Please 
refer to the booklet of each academic meeting, and we hope to avoid any mistakes or insufficiencies in our 
summary of the disease with historical aspect to Korea. We expect that every precious product of researches 
and academic activities of KSBD members would be truly included in the revised edition afterwards.
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